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Abstract
The ATP-gated P2X7 receptors (P2X7Rs) play a key role in the release of pro-
inflammatory cytokines in response to immunological challenges. Pannexin 1 
(Panx1), conventionally described as a hemichannel forming protein, was 
suggested to be involved in the formation of  the P2X7 large pore, which provides 
a conduit for large molecules such as fluorescent dyes.
Firstly, this thesis demonstrated that the P2X7R-mediated dye uptake, a 
phenomenon attributed to the activation of Panx1, was suppressed by acidic pH 
and this inhibition was abolished in a P2X7 mutant (aspartic acid 197 to alanine) 
that was insensitive to extracellular pH. Then, the functional properties of human 
or mouse Panx1 in HEK293 cells were analysed in the absence of  the P2X7R. 
The Panx1 currents were not affected by extracellular/intracellular calcium, but 
were reversibly inhibited by adenosine triphosphate (ATP) and non-specific anion 
channel blockers. Ion substitution experiments showed that Panx1 was 
permeable only to monovalent anions and single channel studies revealed a 
medium sized unitary conductance of Panx1 (~ 65 pS). Based on the evidence, 
this thesis concluded that Panx1 is an anion channel but not a hemichannel as 
originally proposed.
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Chapter 1 Introduction
1.1 Pannexins and gap junction proteins 
1.1.1 Gap junction proteins
Cellular functions are tightly regulated by a complex system of cell signalling. In 
multicellular organisms, cell-to-cell communication can be realised by diffusion of 
signal molecules secreted from one cell to the targeted cell(s). Alternatively, 
intercellular communication can also be performed by direct cell-to-cell contact 
transmitting signalling molecules through channels that bridge the cytoplasm of 
two adjacent cells. A gap junction (GJ) is one example of this form of intercellular 
communication. Exchange of  small molecules with a molecular mass up to 1 kDa 
is permitted through gap junctions (Phelan et al, 1998).
A gap junction is formed by a pair of hemichannels. In vertebrates, connexins 
(Cx) had been conventionally considered as the only family of  proteins to form 
hemichannels. A hemichannel is assembled by six connexins and is known as a 
connexon. In invertebrates, a protein family called OPUS (named after the 
founding gene members ogre, passover, unc-7 and shaking-B) was identified as 
the gap junction proteins. These proteins were later renamed as innexins (the 
invertebrate analogue of connexins) but they share no sequence homology with 
connexins (Phelan et al, 1998). 
24
During searches for putative gap junction forming proteins in vertebrates, a three-
membered family was identified based on sequence homology to innexins 
(Panchin et al, 2000). The encoding genes were cloned from rat hippocampal 
neurones in 2003 (Bruzzone et al, 2003). As these proteins are found in 
vertebrates and are homologous to the invertebrate gap junction proteins, they 
are named Pannexin (in Greek, “pan-” means “all, throughout”). 
1.1.2 Phylogenetic relations of pannexins, connexins and innexins
While it is widely agreed that connexins are unrelated to innexins or pannexins 
(White et al, 2004), the evolutionary relationship between pannexins and innexins 
remains controversial. 
Although phylogenetic analysis shows that pannexins are a distinct family, 
different from connexins and innexins at the primary structure level, the sequence 
divergence between pannexins and innexins is slightly smaller (Figure 1.1.1). 
Based on high alignment scores obtained by comparing the regions of  greatest 
similarity, Yen and Saier Jr (2007) believed that pannexins and innexins are 
related by common descent and therefore belong to one superfamily, as was 
originally suggested by Panchin (2005).
Three conserved motifs are identified in pannexins and innexins (see Figure 
1.1.2): (i) a pair of cysteine residues in the predicted first extracellular loop (EC1) 
are conserved (Phelan, 2005), along with 12 to 17 intervening residues flanking 
the two conserved cysteines, in a pattern of C-X12-17-C (X indicates intervening 
residues); (ii) similarly, a C-X18-20-C motif  is found in the predicted second 
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extracellular loop (EC2) of pannexins, but it does not align with the cysteine pair 
in that region in innexins. However, the spacing between two cysteines in 
innexins shares the same profile with a number of  intervening residues ranging 
from 16 to 18 (Phelan, 2005); and (iii) a fully conserved P-X-X-X-W motif exists in 
the predicted second transmembrane (TM2) domain. The proline residue is also 
strictly conserved in the same relative position in connexins. As this residue is 
proposed to be a part of a molecular hinge motif involved in conformational 
changes in response to voltage in connexins (Ri et al, 1999), it may provide a 
functional correspondence among connexins, pannexins and innexins.
26
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Figure 1.1.1 Phylogenetic tree of pannexins, innexins and connexins
The unrooted tree was generated by TreeView, using an alignment of  full amino 
acid sequences of selected members of pannexins, innexins and connexins 
imported from ClustalW. Panx, pannexins; Inx, innexins; Cx, connexins; Hs, 
Homo sapiens (human); Mm, Mus musculus (mouse); Rn, Rattus norvegicus 
(rat); Gg, Gallus gallus (chicken); Dr, Danio rerio (zebrafish); Xt, Xenopus 
tropicalis (frog); Ce, Caenorhabditis elegans (roundworm); Dm, Drosophila 
melanogaster (fruit fly). The scale bar represents the percentage of divergence 
along the branches (0.1=10%).
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1.1.3 Structural comparison of pannexins, connexins and innexins
Pannexins and innexins exhibit common predicted topologies, which is also 
shared by connexins (Figure 1.1.3). Proteins from these families are all predicted 
to have four transmembrane domains and intracellular N- and C- termini 
(Willecke et al, 2002). As discussed previously, in pannexins and innexins, the 
first two transmembrane domains and the first extracellular loop are the most 
conserved regions, whereas similarity decreases in the third and fourth 
transmembrane domains, as well as in the second extracellular loop.
To summarise the evolutionary relationships of these putative gap junction 
proteins, pannexins and innexins share conserved motifs in some regions, but 
their overall sequence homology is very low. These two types of proteins are 
predicted to have very similar topology, which is also seen in connexins. 
However, connexins proved to be evolutionarily unrelated to pannexins and 
innexins due to their minimal sequence homology. In terms of functional linkage, 
many studies have revealed that innexins are functional analogues of connexins 
as gap junction proteins (see review  by Phelan, 2005). However, data in favour of 
the role of pannexins as gap junction proteins remain inconclusive (see Chapter 
1.2.8). Therefore, it is tempting to speculate that, even if  pannexins and innexins 
once belonged to the same superfamily, they must have undergone significant 
sequence divergence during evolution. Throughout this thesis, pannexins, 
innexins and connexins will be addressed as three independent protein families.  
29
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Figure 1.1.2 Conserved motifs of pannexins and innexins
Three conserved motifs are highlighted in colours in the full amino acid sequence 
alignment of  selected members of pannexins and innexins. Two conserved 
cysteine residues of  the C-X12-17-C motif  in EC1 are highlighted in red, those in 
EC2 in blue (note: these two cysteines are not always aligned in all pannexins 
and innexins); the conserved proline and tryptophan residues of  the P-X-X-X-W 
in TM2 are highlighted in yellow. Rectangular boxes indicate predicated 
transmembrane domains. Hs, Homo sapiens (human); Ce, Caenorhabditis 
elegans (roundworm); Dm, Drosophila melanogaster (fruit fly). Accession 
numbers: Panx1 Hs, AAK91714; Inx21 Ce, AAF60654; Inx3 Dm, AAF87944; Inx7 
Dm, NP_788872; Inx12 Ce, AAB93310.
31
Figure 1.1.3 Predicted topological structure of pannexins
Pannexins have four transmembrane domains and the intracellular N- and C- 
termini. The structural features are also shared by innexins and connexins.
32
1.2 Proposed functions of Panx1
The pannexin family has three members (pannexins 1-3) and pannexin 1 (Panx1) 
is the most studied subtype. Since its identification, Panx1 was generally 
considered a hemichannel due to its alleged structural similarity to connexins. 
Most studies on the physiology and pharmacology of Panx1 were designed 
based on the hypothesis of Panx1 being a hemichannel. In this thesis, however, 
evidence against the hemichannnel properties of Panx1 is presented. Therefore, 
the term “hemichannel” is only used when historical findings of Panx1 are 
described. A more accurate term ‘channel’ is used to reflect its better- defined 
identity.
1.2.1 Distribution of pannexins
The initial comprehensive studies of pannexin expression pattern were performed 
at mRNA level. Northern blotting and in situ hybridisation revealed that Panx1 is 
ubiquitously expressed. In rodents, Panx1 was found in the central nervous 
system (CNS), adrenal gland, bladder, eye, thyroid, stomach, prostate, large 
intestine, kidney and liver tissues (Bruzzone et al, 2003). Wide distribution of 
Panx1 was confirmed in human tissues. However, while Panx1 is highly 
expressed in human heart and skeletal muscle, its expression was not detected 
in these tissues in rodents (Baranova et al, 2004). Panx2 is largely restricted to 
the central nervous system and was detected in the rodent spinal cord and the 
brain by Northern blots (Bruzzone et al, 2003). Panx3 mRNA, in contrast, was 
only found by RT-PCR in skin, where both Panx1 and Panx2 are absent 
(Bruzzone et al, 2003). 
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As Panx1 and Panx2 are both highly expressed in the CNS, and because of their 
suggested role as gap junction proteins, which are the morphological correlate to 
electrical synapses, more detailed distribution of Panx1 and Panx2 in the brain 
was investigated by a combination of in situ hybridisation, real-time PCR and 
immunocytochemistry (Ray  et al, 2005; Vogt et al, 2005). Both Panx1 and Panx2 
are abundantly expressed in cortex, hippocampus, reticular thalamus, motor 
neurones of  brain stem and midbrain, the supraoptic and suprachiasmatic nuclei 
of the hypothalamus and the cerebellum (Ray et al, 2005; Vogt et al, 2005). 
1.2.2 Electrophysiological profiles of pannexins
Initial characterisations of the electrophysiological properties of pannexins, 
mainly Panx1, were performed in the Xenopus laevis oocyte expression system. 
Voltage clamp recordings performed on single oocytes injected with Panx1 
mRNA revealed Panx1-mediated currents, which increased with depolarisations 
from –40 mV to +60 mV (Bruzzone et al, 2003). Outward rectifying currents were 
induced when the oocyte was stepped to voltages more positive than +20 mV. 
The channel opening was not affected by external calcium, which was different 
from most connexin channels (Ebihara et al, 2003). The currents were assumed 
to be non-selective (merely to reflect Panx1’s hemichannel property) but no 
detailed analysis was reported. Activation kinetics of Panx1-mediated currents 
were faster than those reported for connexins hemichannels (e.g. Cx46) (Figure 
1.2.1, left). Injection of  Panx2 and Panx3 mRNA did not result in membrane 
currents (Bruzzone et al, 2003). However, co-expression of  Panx1 with Panx2 
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induced similar outward currents as Panx1 alone, although the current 
amplitudes were significantly reduced (Bruzzone et al, 2003). 
Gap junction activities can be measured by physically placing two oocytes 
together, referred to as “pairing” oocytes. In paired oocytes, the ability of 
homomeric Panx1 or heteromeric Panx1/Panx2 to form intercellular channels 
was tested by voltage-clamp (Bruzzone et al, 2003). Panx1 alone and in 
combination with Panx2 were both able to assemble intercellular channels, which 
were demonstrated by junctional currents (Figure 1.2.1, right). Panx1 or Panx1/
Panx2 mediated-junctional conductance was insensitive to transjuctional 
potential. The junctional currents were linear with between -60 and +60 mV. Even 
at higher transjunctional potentials, the conductance of intercellular channels 
deviated only a little from the initial value (Bruzzone et al, 2003). Homomeric 
Panx2 and Panx3 failed to show  intercellular channel currents (Bruzzone et al, 
2003).
Panx1 currents have also been recorded from HEK cells transiently-expressing 
human or mouse Panx1 using whole-cell patch clamp technique (Pelegrin and 
Surprenant, 2006). In agreement with the results obtained from the oocyte 
system, outward rectifying Panx1 currents were observed from single uncoupled 
Panx1-expressing HEK cells (Figure 1.2.2). The Panx1 currents were activated in 
the positive range of potentials (> +10 mV) and can be inhibited by typical Panx1 
blockers. 
Single channel recordings of  Panx1 were attempted by Bao et al (2004) using 
inside-out membrane patch of  oocyte expressing human Panx1 (hPanx1). Unlike 
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results from whole-cell recordings, a linear current-voltage relationship for 
hPanx1 single channel currents was observed. Depending on the ionic 
composition of the recording solution, a unitary conductance was calculated to 
have a value of  475 pS (in potassium gluconate solution) or 550 pS (in potassium 
chloride solution). In addition to the full open and close states, four intermediate 
states were detected, giving 5 to 90% of the maximal conductance. The authors 
were unable to record these single channel activities from control oocytes (Bao et 
al, 2004). However, pharmacological verification of these Panx1-associated 
currents remained to be established.
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Figure 1.2.1 Voltage-dependent properties of pannexin hemichannels and 
intercellular channels (Barbe et al, 2006)
Left: depolarising steps up to +60 mV were applied to cells that were initially 
clamped at -40 mV. Current of Cx46 hemichannels evoked by depolarisation to 
+60 mV is shown in red for comparison. 
Right: transjunctional currents between two paired oocytes. Both cells were 
initially clamped at -40 mV. Depolarising steps up to +120 mV were given to one 
of the paired oocytes while the other one was kept at the holding potential. For 
comparison, the Cx36 transjunctional currents are shown superimposed in red.
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Figure 1.2.2 Human Panx1 current-voltage relationships (Pelegrin and 
Surprenant, 2006)
Currents in response to ramp voltages from –120 mV to +80 mV from human 
Panx1 transfected HEK cells, in the presence of 5 µM carbenoxolone (CBX) (left) 
or 100 µM of a Panx1 mimetic peptide, 10Panx1 (right).
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1.2.3 Pharmacological features of Panx1
As pannexins were first assumed to be associated with gap junction proteins, 
their sensitivity to common gap junction and hemichannel blockers was 
investigated by electrophysiological and biochemical approaches. 
Pharmacological profile of  heteromeric Panx1/Panx2 was similar to that of 
homomeric Panx1 (Bruzzone et al, 2005), so only the properties of  homomeric 
Panx1 will be discussed below. Chemical structures of the compounds discussed 
below are presented in Figure 1.2.3.
Flufenamic acid, a chloride channel blocker with some inhibitory effect on 
connexin channels (Srinivas and Spray, 2003), has been show  to partially 
suppressed (by ~30%) Panx1-mediated currents in oocytes only at the highest 
concentration of 300 µM (Bruzzone et al, 2005). At 300 µM, flufenamic acid was 
able to block Cx46 completely (Srinivas and Spray, 2003). Moreover, inhibition of 
Panx1 currents only occurred at high positive potentials (Bruzzone et al, 2005). 
Such a difference between pannexins and connexins in the sensitivity to 
pharmacological tools could be exploited to select these two similar protein 
families. 
Under the same experimental conditions, Panx1-mediated currents were much 
more sensitive to carbenoxolone (CBX) than flufenamic acid. CBX is synthetic 
derivative of glycyrrhizinic acid. The precursor of CBX, "-glycyrrhetinic acid ("GA) 
showed similar inhibitory effects on Panx1 (Bruzzone et al, 2005). CBX inhibited 
Panx1 currents in a dose-dependent manner with an IC50 of  5 µM. The inhibitory 
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effects were fully reversible even at the highest concentration tested (100 µM). 
The incubation time with CBX did not affect the level of inhibition (Bruzzone et al, 
2005), in fact the onset of inhibition was almost immediate (Ma et al, 2009). CBX 
appeared to alter the kinetics of  Panx1 channel closure. Closure of  the Panx1 
channel was calculated to be 10 times faster in the presence of CBX (Bruzzone 
et al, 2005). 
Therapeutic applications of CBX include treatment of gastritis and ulcers and 
improvement of cognitive functions (Sandeep et al, 2004). At the cellular/
molecular level, CBX has long been used as a gap junction blocker. However, 
inhibition of connexins, or Cx46 in particular, required a higher threshold 
concentration of CBX than for Panx1 and the maximal inhibitory effects were less 
significant (Bruzzone et al, 2005). In addition, CBX was reported to induce 
changes in liver mitochondrial permeability and trigger the apoptotic pathway, 
which was evident by the loss of cytochrome c (Salvi et al, 2005). Recently, CBX 
was shown to be an effective blocker of  the swelling-induced currents (Benfenati 
et al, 2009) and glutamate release from astrocytes (Ye et al, 2009). Whether 
these inhibitory effects were due to the inhibition of Panx1 remains unknown.
Probenecid, a drug clinically used to treat gout, was found to inhibit Panx1 
currents without affecting connexins (Silverman et al, 2008). Unlike other Panx1 
blockers, probenecid is much less potent and has to be administered in mM 
concentrations to exhibit inhibitory effects.
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Other gap junction/hemichannel blockers, such as heptanol, mefloquine or 
Gap27, a connexin mimetic peptide, failed to affect the ATP-evoked dye uptake, 
which was a function attributed to Panx1 (Pelegrin and Surprenant, 2006).
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Figure 1.2.3 Chemical structures of common Panx1 blockers
Chemical structures of  flufenamic acid, probenecid, "-glycyrrhetinic acid and 
carbenoxolone were obtained from PubChem (National Centre for Biotechnology 
Information, National Library of Medicine, USA; http://pubchem.ncbi.nlm.nih.gov).
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1.2.4 Panx1 mimetic peptides
Mimetic peptides are commonly used to interfere with gap junction functions. 
They are designed to align and interact with sequences in the highly conserved 
extracellular loops, which are expected to form docking of two adjacent 
hemichannels. It is not clear as to how exactly these mimetic peptides work. 
Connexin/pannexin mimetic peptides have been extensively used both in vivo 
and in vitro. Table 1.2.1 summarises properties of peptides that have been 
reported in the literature. The effects of  these peptides are mainly demonstrated 
by inhibition of: (i) dye transfer. Matsue et al (2006) demonstrated a significant 
inhibition of  dye-coupling between bone marrow-derived dendritic cells by 
43Gap27. Similar inhibition of dye transfer was observed in cultured vascular cells 
and bovine corneal endothelial cells (Martin et al, 2005; Gomes et al, 2006). 
10Panx1 inhibited the P2X7-Panx1-associated ethidium bromide uptake in both 
HEK-P2X7 cells and peritoneal macrophages (Pelegrin and Surprenant, 2006); 
(ii) propagation of  calcium waves. Propagation of a calcium wave to the 
neighbouring cells can be attenuated by various connexin mimetic peptides in 
different types of  native cells or in cell lines (Boitano and Evans, 2000; Pearson 
et al, 2005b; De Vuyst et al, 2006; Gomes et al, 2006); (iii) Cx/Panx1-mediated 
currents. In the presence of connexin mimetic peptides, a macroscopic gap 
junctional conductance (Gj) was significantly reduced in paired A7r5 cells (Kwak 
and Jongsma, 1999). 10Panx1 abolished the typical outward rectifying currents 
activated by Panx1 (Pelegrin and Surprenant, 2006). In addition, 10Panx1 
inhibited the NMDA activation-triggered currents, which were attributed to the 
openings of Panx1, in pyramidal neurones (Thompson et al, 2008); or (iv) release 
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of ATP. Both connexin and pannexin hemichannels have been proposed as the 
release pathway for neurotransmitters including ATP (see Chapter 1.2.6). The 
hypothesis was supported by suppression of ATP release by connexin mimetic 
peptides (Braet et al, 2003; De Vuyst et al, 2006). Inhibition of calcium waves and 
release of ATP are often associated. This is because cells release ATP, which 
stimulates the purinoceptors in adjacent cells leading to a P2Y-stimulated calcium 
release from the endoplasmic reticulum.
In addition, connexin mimetic peptides have been shown to block endothelium-
derived hyperpolarising factor (EDHF)-type electrical signalling in rat arteries in a 
connexin-specific manner (Chaytor et al, 2004; Lang et al, 2007). The 43Gap27 
peptide was used to inhibit expression of GLT-1, a major glutamate transporter 
subtype in the cortex (Gomes et al, 2006), and Alexa-546-tagged Cx43 mimetic 
peptide was employed to track hemichannels in HeLa cells (Dermietzel et al, 
2003).
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Peptides Cx/Px Residues Sequence Position References
32Gap24 Cx32 110-122 GHGDPLHLEEVKC IL De Vuyst et al, 2006
37,40Gap26 Cx37 Cx40 64-76 VCYDQAFPISHIR EL1
Chaytor et 
al, 2004
43Gap26 Cx43 63-75 VCYDKSFPISHVR EL1
Boitano and 
Evans, 
2000; Braet 
et al, 2003; 
Seki et al, 
2004; De 
Vuyst et al, 
2006; Lang 
et al, 2007
32Gap27 Cx32 182-191 SRPTEKTVFT* EL2 De Vuyst et al, 2006
40Gap27 Cx40 199-209 SRPTEKNVFIV* EL2 Chaytor et al, 2004
37,43Gap27 Cx37 Cx43 201-210 SRPTEKTIFII* EL2
Boitano and 
Evans, 
2000; Seki 
et al, 2004; 
De Vuyst et 
al, 2006; 
Matsue et 
al, 2006; 
Figiel et al, 
2007; Lang 
et al, 2007
43Gap36 Cx43 191-209 KRDPCPHQVDCFLSRPTEK** EL2
Boitano and 
Evans, 
2000
L2 Cx43 119-144 DGVNVEMHLKQIEIKKFKYGIEEHGK IL
Seki et al, 
2004
P180-195 Cx43 180-195 SLAAVYTCKRDPCPHQ EL2
Kwak and 
Jongsma, 
1999
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Peptides Cx/Px Residues Sequence Position References
P177-192 Cx40 177-192 FLDTLHVCRRSPCPHP EL2
Kwak and 
Jongsma, 
1999
10Panx1 Px1 74-83 WRQAAFVDSY EL1
Pelegrin 
and 
Surprenant, 
2006, 2007; 
Thompson 
et al, 2008
Table 1.2.1 Summary of connexin and pannexin mimetic peptides
Cx, connexins; Px, pannexins; IL, intracellular loop; EL1, extracellular loop 1; 
EL2, extracellular loop 2. * all Gap27 peptides incorporate a sequence SRPTEK, 
which is present in most connexins. ** Gap36 also contains SRPTEK sequence 
but it is less effective than the shorter Gap27 peptides (Boitano and Evans, 
2000). 
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1.2.5 Panx1 in calcium wave propagation
Stimulation of cells can often initiate increases in intracellular free calcium and 
such calcium rise can propagate to neighbouring cells. Generation of intercellular 
calcium waves has been proposed to follow  three possible mechanisms: (i) 
Diffusion of inositol 1,4,5-trisphosphate (IP3) through gap junctions (Sanderson, 
1995); (ii) Non-contacting cells can also participate in propagation of  calcium 
waves using ATP as an extracellular messenger (Cotrina et al, 1998). Upon 
stimulation, ATP is released via, possibly, Panx1 (see Chapter 1.2.6) from the 
initiating cell and then activates P2Y receptors in the surrounding cells, thus 
triggering calcium wave (Locovei et al, 2006); (iii) More recently, Vanden Abeele 
et al (2006) demonstrated that Panx1 channels were calcium permeable. In the 
same study, the authors also proposed that Panx1 might form calcium ‘leak’ 
channels in the endoplasmic reticulum (ER) membrane (Vanden Abeele et al, 
2006). 
1.2.6 Release of ATP
In addition to its role as a universal energy source, adenosine triphosphate (ATP) 
is also a ubiquitous and ancient intercellular signalling molecule. Extracellular 
ATP activates purinergic receptors, including the metabotropic P2Y receptors (8 
P2Y subtypes: P2Y1, 2, 4, 6, 11, 12, 13, 14) and the ionotropic P2X receptors (P2X1-
P2X7) (Burnstock, 2007). Intracelluarly, ATP is critical in signalling transduction. It 
is the source of  phosphate groups in phosphate transfer reactions by kinases and 
can be transformed to cyclic AMP (cAMP), the second messenger molecule, by 
adenylate cyclase. Although the gradient of ATP concentration is outwardly 
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directed (the gradient is approximately 109, probably the highest in biology), 
release of ATP from cells cannot be realised by simple diffusion because ATP is 
membrane impermeable. ATP is released during cell lysis under necrotic 
conditions. Other than that, the exact pathways of ATP secretion are not well 
defined. A few  pathways for ATP release may exist and they will be discussed in 
the following chapter.
1.2.6.1 Candidates for the ATP release pathway
Exocytosis
In neurones, exocytosis is a common mechanism of neurotransmitter release. 
ATP, a well-established neurotransmitter (Burnstock, 2006), has been therefore 
proposed to follow  the same release pathway. Early publications reported that a 
high concentration of ATP was found in some secretory vesicles (Douglas and 
Poisner, 1966; Dowdall et al, 1974). Pharmacological tools used to block vesicle 
trafficking disrupted mechanosensitive ATP release in oocytes, suggesting a role 
of exocytosis in the release mechanism (Maroto and Hamill, 2001). The 
exocytotic release is calcium dependent (Santos  et al, 1999). ATP exocytotic 
release can follow  several different pathways: (i) co-existence of ATP- and 
glutamate-containing vesicles was observed in hippocampus and in cortex but 
the release of ATP occurred independently from, although simultaneously with, 
the release of  glutamate (Pankratov et al, 2006; Pankratov et al, 2007); (ii) ATP 
can be co-stored and co-released with !-aminobutyric acid (GABA) in the 
hypothalamic and in the spinal neurones (Jo and Schlichter, 1999; Jo and Role, 
2002), or with acetylcholine (Reigada et al, 2003) or noradrenaline (Sesti et al, 
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2002) in the periphery; (iii) ATP can be packed into and released from vesicles 
that contain ATP only, separately from other neurotransmitters (Robertson and 
Edwards, 1998). 
Vesicular exocytotic release of ATP is also seen from cells other than neurones 
and can be suppressed pharmacologically. For example, Bodin and Burnstock 
(2001) demonstrated that ATP release from vascular endothelial cells was 
vesicular by showing a significant attenuation of  level of ATP release by inhibitors 
of vesicular transport (monensin and N-ethylmaleimide). These inhibitors reduced 
the hypoxia-induced vesicular release of ATP from rat oasteoblasts (Orriss et al, 
2009). Similar reductions of ATP release were observed from urothelia when the 
cells were treated with monensin and brefeldin A as a result of  disruption of 
formation and trafficking of  vesicles (Knight et al, 2002). In astrocytes, 
bafilomycin A1 was employed to interfere with formation of synaptic vesicles, 
thereby reducing the release of ATP (Coco et al, 2003).
ABC transporter
ATP-binding cassette (ABC) proteins form a large family of transmembrane 
proteins that bind ATP. They transport various molecules across the membrane 
using the energy generated through the hydrolysis of ATP (Dean and Allikmets, 
1995). Owing to this feature, the ABC proteins were hypothesised to be a 
possible pathway for ATP release. The two most common members of the ABC 
family have been proposed to be involved in this pathway: P-glycoprotein, the 
product of  the multidrug resistance gene (MDR) and the cystic fibrosis 
transmembrane conductance regulator (CFTR). 
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P-glycoprotein was the first ABC transporter suggested to be involved in the 
transport of  ATP. It was shown that heterologous expression of MDR increased 
ATP release to the medium (Abraham et al, 1993). The level of ATP release was 
proportional to the level of  P-glycoprotein expression in the plasma membrane. 
An ‘ATP channel’ current was observed by patch-clamp recordings from CHO 
cells transfected with the mdr1 gene under conditions where all anions were 
replaced with ATP. 
Another candidate for ATP release pathway is the cystic fibrosis transmembrane 
conductance regulator (CFTR). CFTR functions as a cAMP-activated ATP-
dependent chloride channel but is also a regulator of potassium channels 
(Sheppard and Welsh, 1999). Reisin et al (1994) were the first to demonstrate 
the ATP-conducting channel activities of  CFTR using electrophysiological 
measurements. The association of  CFTR with ATP transport was also supported 
by the observation of outwardly rectifying chloride channel currents activated by 
ATP, which was released by CFTR in response to cAMP (Schwiebert et al, 1995). 
However, the hypothesis of CFTR as an ATP pathway was challenged by many 
other studies. In the work of Reddy et al (1996), ATP permeation through CFTR 
was not observed either in intact organs, polarised human lung cell lines, stably 
transfected mammalian cell lines, or in planar lipid bilayers reconstituted with 
recombinant CFTR. The authors thought their results were compatible with a 
difference between the pore diameter of  CFTR (< 5.5 Å) and the dimension of 
ATP (10.5 Å). Sugita et al (1998) found that CFTR chloride channels were not 
associated with ATP conductance as various CFTR chloride channel inhibitors 
and mutations in key positions that impaired CFTR chloride conductance had no 
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effect on ATP conductance. However, they demonstrated that the CFTR-
associated ATP channel was gated by a common phosphorylation- and 
nucleotide hydrolysis- dependent mechanism as to CFTR. More recently, 
possible interactions/associations between CFTR and connexins or Panx1 in 
ATP release were proposed by at least two groups (Kotsias and Peracchia, 2005; 
Jiang et al, 2007). A plausible explanation for the discrepancy is that CFTR is a 
regulator of the ATP channel, rather than an ATP channel per se. Overall, the 
relevance of CFTR for ATP release is questionable.
Maxi-anion channels
Cell swelling is known to stimulate ATP release (Wang et al, 1996). Originally, the 
volume-sensitive outwardly rectifying (VSOR) intermediate-conductance anion 
channel was proposed to be involved in ATP release (Strange et al, 1996). 
However, VSOR channel blockers failed to inhibit ATP release (Mitchell et al, 
1998). Similarly, Gd3+, a swelling-induced ATP release inhibitor, was unable to 
block VSOR currents (Hazama et al, 1999). Another type of  anion channel, the 
volume- (and voltage-) dependent ATP-conductive large conductance (VDACL) 
channel, was also considered as the swelling-induced ATP release conduit 
(Sabirov et al, 2001). The ATP-mediated currents were recorded when all anions 
were replaced with ATP4-; the channel had a very large unitary conductance 
(about 400 pS); and was sensitive to the inhibitors of swelling-induced ATP 
release (Bell et al, 2003). So far, however, all the evidence in favour of VDACL as 
an ATP release pathway was presented by one group, and has to be 
independently confirmed.
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Connexins
A link between ATP release and connexins was initially suggested based on the 
observations that intercellular calcium wave propagation was tightly coupled to 
connexin expression and required extracellular ATP (Cotrina et al, 1998). The 
ability to release ATP was acquired, or significantly increased, in connexin over-
expressing glioma cells (Cotrina et al, 1998), HeLa cells (Elfgang et al, 1995) and 
HEK 293 cells (Toyofuku et al, 1998). Release of ATP from Xenopus oocytes 
endogenously expressing Cx38 was simultaneous with hemichannel opening, 
was inhibited by gap junction blockers and anti-sense Cx38 mRNA, and was 
increased by overexpression of Cx38 (Bahima et al, 2006). ATP release through 
connexins was also reported from corneal endothelial cells (Gomes et al, 2005), 
MLO-Y4 osteocytes (Genetos et al, 2007) and from retinal pigment epithelium 
(Pearson et al, 2005a).
Typically, such channel activity was only observed in non-physiologically low 
calcium concentrations (Li et al, 1996) or at potentials only achieved in 
experimental settings (i.e. > +60mV) for non-excitable cells (Contreras et al, 
2003). This therefore raises the question of  whether ATP release via connexins 
occurs under physiological conditions. 
There is also evidence against the concept that connexin is the ATP release 
conduit. For example, the velocity of intercellular calcium wave propagation was 
not altered in astrocytes from Cx43 deficient mice (Suadicani et al, 2003). 
However, this may not be sufficient to reject the role of Cx43 in ATP release, as 
astrocytes are also able to release ATP in an exocytotic manner.
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1.2.6.2 Panx1 as an ATP conduit
The role for Panx1 in ATP release was first proposed by Dahl and colleagues with 
the following main evidence obtained from oocytes expressing Panx1 (Bao et al, 
2004): (i) A reversal potential of +25mV was observed with a 100:1 (out:in) 
gradient of potassium ATP applied to plasma membrane. The reversal potential 
would be around +60mV, if there was only potassium permeation across the 
membrane, so ATP must contribute to the overall permeation of  the channel; (ii) 
ATP efflux was observed when oocytes expressing Panx1 were depolarised by 
high potassium solution (depolarisation induces Panx1 channel opening); and (iii) 
Panx1 is expressed at the plasma membrane where ATP release takes place 
(Locovei et al, 2006). 
The involvement of Panx1 in ATP release has also been observed by other 
groups. For example, Panx1 was proposed to provide an ATP conduit in the taste 
bud cells to mediate taste sensation (Huang et al, 2007b), in the retinal ganglion 
cells (Reigada et al, 2008) to respond to increase of ocular pressure, and in the 
airway epithelia to regulate the mucociliary clearance (Seminario-Vidal et al, 
2009). However, these studies only used relatively non-specific inhibitors (CBX 
and/or probenecid) to verify the functional role of Panx1.  
1.2.7 Tumour-suppressor effects
Panx1 was suggested to have a tumour suppressive role (Lai et al, 2007). The 
main evidence for this is that no pannexin was detected in C6 glioma cells by RT-
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PCR, but all three pannexins were present in its non-tumourigenic counterpart, 
the primary astrocytes. Exogenous introduction of Panx1 changed morphology of 
the glioma cells and reduced cell proliferation, motility and in vivo tumour growth 
in athymic nude mice. However, pannexins were found in other human glioma 
cell lines. This was explained by the authors as the lack of pannexin transcripts 
may only apply to a specific subset of gliomas (i.e. C6 glioma cells) or loss of 
pannexin expression/function may occur at a post-transcriptional level.
1.2.8 Panx1 and gap junction formation?
Contrary to connexins, there is no evidence demonstrating that endogenous 
pannexins form gap junctions. Immunostaining against Panx1 failed to display 
gap junction plaques in various neuronal cell lines and primary cultured cells 
(Huang et al, 2007a). Key evidence against Panx1 forming gap junctions is a 
glycosylation site found on the second extracellular loop (asparagine at 254) 
(Boassa et al, 2007). Although this residue is essential in the correct trafficking of 
the protein to the plasma membrane, the large sugar linked to the protein, as a 
result of glycosylation, acts as a steric hindrance to prevent docking of two 
adjacent pannexins. In addition, pannexins lack a third cysteine in each 
extracellular loop compared with connexins, while these two additional cysteines 
have been proposed important in stabilising formation of gap junctions (Penuela 
et al, 2007). Finally, opening of gap junction formed by connexins is known to be 
controlled by extracellular divalent cations (Ca2+ and Mg2+) (Ebihara et al, 2003). 
All studies in the literature, including this thesis, agree that the functions of Panx1 
are not affected by extracellular divalents, clearly demonstrating that Panx1 is not 
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subject to modulation of gap junction activities, which further diminishes the 
likelihood of Panx1 forming gap junctions. 
Although functional gap junction currents were observed from Panx1 channels in 
paired oocytes (Bruzzone et al, 2003), it should be noted that paired oocytes 
represent a “forced” system that may exaggerate weak tendencies of  forming 
intercellular communication and therefore may not reflect Panx1’s true function. 
Moreover, expression of  Panx1 in Xenopus oocytes may receive insufficient post-
translational modifications, including glycosylation, which is a key factor in the 
formation of gap junctions. Therefore, there is sufficient evidence to conclude that 
Panx1 does not form gap junctions like connexins. 
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1.3 Panx1 and the P2X7 receptors 
1.3.1 The P2X7 receptors in inflammation
The P2X7 receptor (P2X7R) is a member of the ATP ligand-gated P2X receptors 
family. They are non-selective cation channels that generally considered to form 
as homomultimers of several subunits (see review  by North, 2002), although 
recent data suggested that P2X4 and P2X7 can form functional heteromeric 
receptors (Guo et al, 2007). Each subunit has intracellular N- and C- termini and 
two transmembrane domains, which are separated by a large cysteine-rich 
extracellular loop. The P2X7R has a much longer C- terminus compared with 
other P2X receptors (Surprenant et al, 1996). 
Compared with other members of  the P2X family, P2X7 has some unique 
features. First, activation of P2X7 requires a higher concentration of ATP (> 1 
mM) (Surprenant et al, 1996). This property may reflect a role of P2X7 under 
pathophysiological conditions where high concentrations of extracellular ATP are 
present. Second, P2X7 receptors demonstrate an increasing permeability to large 
molecules, or a “pore” activity, upon stimulation by ATP (Rozengurt and Heppel, 
1975). This pore allows passage of  molecules up to 900 Da (Steinberg et al, 
1987). The pore properties are usually assayed by uptake of  large molecular 
weight dyes, such as ethidium and YoPro1 (Collo et al, 1997).
Initially, the “pore” was considered an intrinsic feature of  the P2X7 protein, formed 
by dilatation of the ion channel. The increase of  permeability was progressive. 
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The strongest support for the dilatation hypothesis is that most antagonists 
blocked both the P2X7 current and YoPro1 uptake (Virginio et al, 1999). 
However, other studies demonstrated the possibility that a distinct protein may 
serve as the permeation pathway for large molecules. Firstly, maitotoxin, a 
marine toxin, can activate a dye uptake pore that is similar to the P2X7 pore 
(Schilling et al, 1999). The maitotoxin-induced dye uptake can occur in the 
absence of P2X7. Secondly, P2X7 currents can be blocked by calmidazolium 
while dye uptake remained unaffected (Virginio et al, 1997). Thirdly, P2X7 ion 
channel activation and dye uptake activity do not always co-exist in some 
expression systems (Petrou et al, 1997). Lastly, larger molecules (for example, N-
methyl-D-glucamine, NMDG) do not use the same permeation pathway (Jiang et 
al, 2005), indicating involvement of a protein other than P2X7 itself.
It has to be noted that fluorescent dye uptake is used merely as a measurement 
of the pore formation. No real physiological significance has been shown to be 
attached to the dye uptake phenomenon. However, study of the P2X7-mediated 
dye uptake may provide insight into mechanisms of P2X7 pore formation, which 
is responsible for the downstream signalling pathways and processing and 
release of biologically active molecules. 
P2X7 receptors are widespread and identified in the pancreas, skin, 
gastrointestinal tract, kidney, bladder, urethra, vas deferens, heart, blood vessels, 
bone etc and the expression of P2X7 receptors can be seen in many cell types 
including epithelia, smooth muscle cells, glia cells and immune cells (see review 
by Burnstock and Knight, 2004). Because the P2X7 receptors are activated by 
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high concentrations of  ATP that are found at sites of injury or inflammation (North, 
2002), a link between P2X7 and immunological responses, such as inflammation, 
seemed logical. Before the identification of the P2X7 receptor, a few  studies had 
already shown that ATP was a strong inducer of interleukin 1" (IL-1") release 
(Hogquist et al, 1991; Perregaux and Gabel, 1994). Studies on mice lacking P2X7 
receptors conclusively established the role of  P2X7 in the ATP-dependent 
maturation and release of IL-1" (Solle et al, 2001; Chessell et al, 2005). 
Peritoneal macrophages isolated from P2X7 knock-out mice produced 
comparable amounts of  pro-IL-1" as those produced by the wild type, but failed 
to generate and release mature IL-1" when challenged with ATP (Solle et al, 
2001). The knock-out animals demonstrated reduced inflammatory responses, 
establishing P2X7 as a key player in the inflammation process and making it a 
novel target in anti-inflammatory drug development. 
1.3.2 Panx1 as the “large pore” for the P2X7–mediated dye uptake
Candidates for this putative P2X7-activated pore were selected from proteins that 
are (i) present in the membrane of cells where P2X7 receptors are abundantly 
expressed (e.g., macrophages); (ii) able to form interactions with P2X7; and (iii) 
able to show  dye uptake functions. Non-selective hemichannel proteins seem to 
fit these criteria nicely, although the involvement of connexins have been ruled 
out (Steinberg and Di Virgilio, 1991; Hickman et al, 1996). In contrast, the role of 
Panx1 was proposed as the dye uptake pathway associated with the P2X7 
receptor (Pelegrin and Surprenant, 2006; Locovei et al, 2007).
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Supporting evidence that Panx1 can act as the “large pore” was obtained by the 
study of Pelegrin and Surprenant (2006): firstly, inhibition of  Panx1 by small 
interference RNA (siRNA) in HEK cells expressing P2X7, by a Panx1-mimetic 
peptide (10Panx1), or by CBX resulted in a blockade of  dye uptake. Secondly, 
over-expression of Panx1 led to an increased dye uptake in P2X7-co-expressing 
cells or constitutive dye uptake in the absence of the P2X7 receptors. Moreover, 
Panx1 was found to be highly expressed in macrophages, where P2X7 receptors 
are endogenously expressed. The interaction between Panx1 and P2X7 was 
confirmed by co-immunoprecipitation. Blockade of Panx1 inhibited dye uptake 
but did not affect the ionic current of P2X7 when they were co-expressed in HEK 
cells, indicating P2X7-coupled dye uptake is a distinct pathway from the ion 
channel function and is mediated by Panx1.
1.3.3 Involvement of Panx1 in the P2X7-mediated IL-1" processing and 
release
Interleukin-1 (IL-1) belongs to a family of pro-inflammatory cytokines mediating 
host defence response to immunological challenges such as infection, injury and 
inflammation (Dinarello, 2002). IL-1# and IL-1" are the two main members of  the 
IL-1 family, which up-regulate expression of  genes related to inflammation, 
including cyclooxygenase type 2 (COX-2), type 2 phospholipase A and inducible 
nitric oxide synthase (iNOS) genes (Dinarello, 2002). IL-18 is a similar cytokine 
that shares structural and some functional features with IL-1" (Dinarello, 2002). 
Both IL-1 and IL-18 promote expression of adhesion molecules on endothelial 
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cells (Dinarello, 2002). IL-1 also enhances bone marrow  differentiation (Dinarello, 
2002).
Unlike other cytosines, IL-1 lacks a leader sequence and therefore does not 
follow  the classic ER – Golgi secretion pathway (Rubartelli et al, 1990). Bacterial 
products (e.g. lipopolysaccharide, LPS), or any pathogen-associated molecular 
patterns (PAMPs), are received by their specific receptors on the membrane (or 
pattern recognition receptors, PRRs). Among them, toll-like receptors (TLRs) are 
the best-known family (Kanneganti et al, 2007). PAMPs trigger transcription of 
the IL-1" gene (see review  by Ferrari et al, 2006). The IL-1" protein is initially 
synthesised as a 31 kDa pro-cytokine and accumulated in the cytoplasmic 
compartments (Ferrari et al, 2006) . The precursor is biologically inactive until it is 
proteolytically processed by its specific enzyme caspase-1 (casp1, or known as 
IL-1" converting enzyme, ICE) (Thornberry et al, 1992). The mature IL-1" is 17 
kDa. 
Under normal circumstances, caspase-1 (casp1) is inactive in the cytoplasm and 
appears in a 45 kDa pro-form (pro-casp1). When the cells are challenged by 
various inflammatory stimuli (PAMPs), pro-casp1 undergoes proteolytic cleavage 
and becomes its active 20 kDa form, casp1, which consequently catalyses IL-1" 
activation. However, stimulation by PAMPs alone is not sufficient to trigger IL-1" 
maturation and externalisation. In fact, in vitro, only 10% of  the total pro-IL-1" is 
processed and released from stimulated monocytes (Dinarello, 2004). This 
suggests an additional signal is required to turn on the whole process of IL-1" 
activation and this signal will perhaps especially target maturation of pro-casp1. 
60
ATP, an example of  the so-called damage-associated molecular patterns 
(DAMPs), often serves the role as the second hit to stimulate IL-1" processing 
and release (Ferrari et al, 1997). 
A protein complex that triggers activation of casp1 was identified and named 
‘inflammasome’ (Martinon et al, 2002). An inflammasome is a cluster of proteins 
co-ordinated by a central scaffold protein. Two main inflammasome scaffold 
proteins identified so far are the ICE protease-activating factor (IPAF) and the 
NACHT, LRR and PYD-containing proteins (NALPs). An inflammasome scaffold 
protein has three core parts. The C-terminal leucine-rich repeat (LRR) is 
responsible for binding of PAMPs. The central NACHT (a domain present in 
neuronal apoptosis inhibitor protein, class II transactivator, heterokaryotic 
incompatibil ity factor-E and telomerase-associated protein1) helps 
oligomerisation of the protein. The N-terminal domain interacts with caspases. 
Three motifs in the N-terminal have been identified. They are caspase-
recruitment domain (CARD), pyrin domain (PYD) and baculovirus inhibitor of 
apoptosis repeat (BIR). In-depth information of inflammasomes can be found in a 
recent review by (Di Virgilio, 2007).
ATP-induced IL-1" release is abolished in mice lacking NALP3 or ASC 
(apoptosis-associated speck-like protein containing a CARD, an adaptor protein 
linking NALP3 and casp1), but not in those lacking IPAF (Sutterwala et al, 2006). 
This suggests a strong association between P2X7 and NALP3 inflammasome, 
but how  is P2X7 involved in NALP3-mediated activation of casp1? It is now 
generally accepted that potassium (K+) efflux is a link between P2X7 and NALP3. 
To support this argument the following was observed: (i) nigericin, a potassium 
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ionophore, and maitotoxin, a sea toxin, were able to activate the NALP3 pathway 
in the absence of ATP (Mariathasan et al, 2006; Sutterwala et al, 2006); and (ii) 
similarly, a few  other bacterial toxins were shown to have the same effects 
whereby the membrane was permeablised, leading to depletion of intracellular 
potassium, formation of inflammasome and activation of  casp1 (Gurcel et al, 
2006). Considering that activation of  P2X7 induces K+ efflux, it seems logical to 
conclude that K+ efflux is a key mediator in the P2X7–NALP3 pathway for casp1 
activation. However, the mechanism by which K+ promotes NALP3 activation is 
still unknown, although it was suggested that K+ depletion might cause a 
conformational change in the inflammasome complex, thus triggering activation 
of the latter (Di Virgilio, 2007).
Recently, Panx1 was proposed to participate in the P2X7–NALP3-casp1-IL-1" 
signalling cascade. Upon certain secondary stimulation, Panx1 mediated IL-1" 
processing/release in LPS-primed cells, either in the presence of P2X7R 
(secondary stimulus being ATP) (Pelegrin and Surprenant, 2006), or in the 
absence of P2X7R (secondary stimulus being nigericin or maitotoxin) (Pelegrin 
and Surprenant, 2007). IL-1" release triggered by any of  these activators was 
blocked by the use of Panx1 siRNA, Panx1-mimetic peptide, 10Panx1, or a non-
specific Panx1 inhibitor CBX (Pelegrin and Surprenant, 2006; Pelegrin and 
Surprenant, 2007). Surprisingly, inhibition of  Panx1 did not prevent K+ efflux, 
while IL-1" release was completely blocked (Pelegrin and Surprenant, 2007). 
This implies K+ efflux is an upstream event of  and is required for Panx1 
activation. However, the underlying mechanism of the involvement of Panx1 in 
the IL-1" process/release is still unknown. 
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The “Two-hit” model
A ‘two-hit’ model is presented here to outline the P2X7 receptor and Panx1-
mediated, NALP3-specific activation of IL-1" processing(Figure 1.3.1). 
PAMPs (e.g. LPS) are the first stimulation and they bind to TLRs on the cell 
membrane to initiate IL-1" and casp1 gene transcription. Biologically inactive pro-
IL-1" and pro-casp1 are synthesised and remain in the cytoplasm. Once a 
second stimulus (in most cases, ATP) appears, the P2X7R is activated, resulting 
in K+ efflux and recruitment and activation of  Panx1. The formation of the NALP3 
inflammasome is subsequently promoted, leading to maturation of casp1. Mature 
casp1 cleaves and converts pro-IL-1" to its bioactive form. However, both the 
function of K+ efflux and the mechanisms of  activation of the inflammasome by 
Panx1 remain unclear.
The reasons why a two-step stimulation mechanism has evolved for the 
processing and release of IL-1" are speculated as follows. First of  all, some 
micro-organisms that the body is exposed to are harmless, therefore, it would be 
wasteful to switch on the host defence system. In addition, as IL-1" is a highly 
potent proinflammatory cytokine, inappropriate release of IL-1" may cause 
serious undesirable body reactions. Hence, the body needs confirmation that the 
initial signal is dangerous, which can be proved by danger signals (i.e. DAMPs) 
derived from the damaged site. A tight ‘two-hit’ regulation ensures processing and 
release of IL-1" is both efficient and accurate.
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Figure 1.3.1 Schematic “Two-hit” model of the P2X7 receptor and Panx1-
mediated IL-1" maturation
PAMPs (such as LPS) activate TLRs on the cell membrane. This leads to gene 
transcription and translation of pro-casp1 and pro-IL-1". The immature form of 
the two proteins remains in the cytoplasm until the cell receives a second 
stimulation from DAMPs (e.g. ATP). The P2X7 receptor is activated by ATP and 
thus recruits and activates Panx1. K+ efflux is triggered by activation of  P2X7 and 
is important, together with activation of Panx1, for formation of NALP3 
inflammasomes. The NALP3 inflammasome cleaves pro-casp1 to mature casp1, 
which subsequently converts pro-IL-1" to its biologically active form, IL-1". In this 
model, the mechanisms how  P2X7 activates Panx1 and how  Panx1 promotes 
NALP3 assembly are unknown. The significance of  K+ efflux in promoting NALP3 
formation is unclear. 
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1.4 Chloride channels 
The permeation studies of Panx1 carried out in this thesis identified Panx1 as an 
anion selective channel. In order to compare the properties of  Panx1 with the 
established chloride (Cl-) channel families, an overview  of the common properties 
of Cl- channels is presented below. In addition, major families of Cl- channels, as 
well as the unidentified volume regulated anion channels (VRAC), are discussed 
in this section. 
1.4.1 Overview
Historically, Cl- channels received less attention than cation channels probably 
because the Cl- channels control “slow” effects on regulating cell functions. These 
“slow” actions include regulation of cell volume, pH, migration and proliferation. 
Another possible reason was the general belief that Cl- was in equilibrium across 
the cell membrane (Coombs et al, 1955). However, it has now  been clearly 
demonstrated that Cl- is actively and constantly transported by a dynamic system 
of Cl- channels and transporters. For example, the N+-K+-Cl- cotransporter, the 
Na+-Cl- cotransporter and the Cl--HCO3- exchanger direct Cl- move inwardly 
whereas the K+-Cl- cotransporter and the Na+-dependent Cl--HCO3- exchanger 
pump Cl- out of the cell. Similarly, Cl- channels, including all the families 
discussed below, also mediate Cl- fluxes across the membrane.
Unlike cation channels, which are generally highly selective for one ionic species, 
Cl- channels have much lower selectivity among monovalent anions. The 
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preference to anions varies among different Cl- channel families. These channels 
are more precisely described as anion channels.
1.4.2 The Cl- channel families 
Differences among Cl- channel families lie in their single channel conductance, 
activation mechanism and preference to anions. Based on their molecular 
identifies, Cl- channels can be classified into the following five classes.
1.4.2.1 The voltage-gated Cl- channel (ClC) family
Members of  the ClC family are voltage-gated Cl- channels and they are the best 
studied Cl- channels. ClCs were initially identified by expression-cloning from the 
electrical organ of a marine fish Torpedo marmorata (Jentsch et al, 1990). Nine 
genes of the ClC family have been found in mammals and they can be divided 
into two groups based on their localisation: ClC-1 (CLCN1), ClC-2 (CLCN2), ClC-
Ka (CLCNKA) and ClC-Kb (CLCNKB) are found on the plasma membrane; 
whereas ClC-3 (CLCN3), ClC-4 (CLCN4), ClC-5 (CLCN5), ClC-6 (CLCN6) and 
ClC-7 (CLCN7) are located intracellularly. In terms of their functions, the 
intracellular ClCs, as well as the bacterial counterparts, are in fact Cl--H+ 
exchangers, while other CICs are voltage-gated Cl- channels. These two 
functional subtypes have tight evolutionary relations, as it has been suggested 
that the channel subtypes evolved from an Cl--H+ exchanger by losing the ability 
to couple proton (Miller, 2006). 
The crystal structure of bacterial ClCs confirms that the proteins have 18 
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segments but only 10 of  them span the plasma membrane (Dutzler et al, 2002). 
The molecular structure of  the mammalian ClC proteins has been established 
based on their homology to the bacterial counterparts. ClCs were predicted to 
form dimers. A "double barrel" model was proposed and supported by single 
channel recordings in which two sets of equally spaced bursting of channel 
openings were observed (Miller and White, 1984). Each subunit of the ClC 
channels is gated by the movement of a glutamate residue in and out of  the ion 
conductance pathway. This is known as the fast gate. Two subunits are 
coordinated to open/close simultaneously by a so-called 'slow  gate', whose 
identity is unclear but may involve a C-terminus domain containing a 
cystathionine-"-synthase (CBS) motif. 
Several genetic disorders are caused by mutations of the ClC genes. ClC-1 plays 
a role in mediating large Cl- conductance in the skeletal muscle, through which it 
repolarises the cell after an action potential. Loss-of-function of the CLCN1 gene 
causes myotonia, a condition characterised by muscular hyperexcitability, as a 
result of disruption of membrane potential in the muscle cells (Klocke et al, 1994). 
The channelopathy of  ClC-2 is controversial. As the predicted role for ClC-2 is to 
keep [Cl-] low  in GABAergic neurones, mutations of  the CLCN2 gene were 
proposed to be associated with idiopathic generalised epilepsy (Haug et al, 
2003). However, the CLCN2 knock-out mice do not present any epileptic 
symptoms (Bosl et al, 2001). ClC-Kb is the renal Cl- channels, which is 
responsible for Cl- reabsorption. Bartter syndrome type III results from loss-of-
function mutations in ClC-Kb with typical symptoms involving impaired renal salt 
balances (Simon et al, 1997). Mutations in the intracellular Cl--H+ exchangers are 
usually associated with defects in acidification of intracellular organelles. For 
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example, ClC-5 mutations affect endosomal acidification, causing Dent's disease 
(Lloyd et al, 1996). Loss-of-function of the CLCN7 gene disrupts acidification of 
resorption lacuna in osteoblasts, leading to osteoporosis (Kornak et al, 2001).
1.4.2.2 Cystic fibrosis transmembrane conductance regulator (CFTR)
Cystic fibrosis (CF) is one of the most common and severe genetic diseases in 
the Caucasian population. The genetic basis for CF was revealed in 1989 by 
positional cloning of  the CFTR gene (Riordan et al, 1989). The CFTR protein is 
an ATP-binding cassette (ABC) transporter that is activated by phosphorylation of 
cyclic AMP (cAMP). Besides 12 transmembrane segments, the CFTR protein 
also has two nucleotide binding domains (NBDs), which are the site for ATP 
binding, and an R domain, which is a regulatory domain containing 
phosphorylation sites. Bear et al (1992) revealed that CFTR is a Cl- channel by 
reconstituting it into artificial lipid bilayers. CFTR is located at the apical side of 
epithelial membranes in tissues such as airways, the intestine and sweat glands. 
It is not completely understood how  malfunctions of  the CFTR cause cystic 
fibrosis. It has been suggested that CFTR deficiency may lead to insufficient 
movement of  halogens (Cl-, I- and thiocyanate), causing mucus formation in the 
lungs. Bacteria hide in the mucus thereby escaping surveillance of the immune 
system (Doring and Gulbins, 2009). In addition to acting as a Cl- channel, CFTR 
also regulates other ion channels, dysfunction of  which may contribute to the 
pathophysiology of CF. For example, in the presence of CFTR, the epithelial Na+ 
channel (ENaC) currents are reduced (Kunzelmann et al, 2000). Failure to 
excrete Na+ from cells may cause increased water reabsorption and create 
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mucus. 
Numerous loss-of-function mutations of the CFTR gene have been found but 
$F508 (deletion of phenylalanine at position 508) is the most common one for 
cystic fibrosis. This mutation accounts for 90% CF cases in Caucasians and 
approximately 70% worldwide (Mitchell et al, 2007).
1.4.2.3 Ligand-gated Cl- channels
Ligand-gated ionotropic GABA (!-aminobutyric acid) and glycine receptors 
mediate inhibitory neurotransmission in the central nervous system (CNS). Upon 
activation by their natural agonist (glycine or GABA), glycine receptor and two of 
the three subtypes of  GABA receptor (GABAA and GABAC) open Cl- channels. 
GABAB receptors are metabotropic G-protein-coupled receptors and will not be 
discussed below in the context of Cl- channels. 
Both glycine and GABA receptors assemble as pentamers. For glycine receptors, 
the pentamer is formed by a combination of two types of subunits (#1-#4 and "). 
The most common combination is 2#1:3" (Cascio, 2006). GABA receptors have 
many more subunits, namely #1-#6, "1-"3, !1-!3, %, &, ', ( and )1-)3. Typically, 
GABAA receptors are composed of two #, two " and one ! subunits (Kash et al, 
2004), whereas GABAC receptors only contain either one or a few  types of ) 
subunits (Bormann and Feigenspan, 1995). 
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Glycine/GABA subunits have four transmembrane domains and extracellular 
amino (N-) and carboxy (C-) termini. Unlike the ClC proteins, five subunits of 
glycine/GABA Cl- channels share a common pore, which is thought to be lined by 
the second transmembrane domain of each subunit (Kash et al, 2004; Webb and 
Lynch, 2007). The long extracellular N- terminus forms the neurotransmitter 
binding site and contains a cysteine disulphide bridge motif, namely the Cys loop. 
The latter is conserved among many ligand-gated ion channels, including the 
nicotine acetylcholine receptors (Lindstrom et al, 1995) and the 5-HT receptors 
(Maricq et al, 1991).
The inhibitory effects of glycine/GABA receptors result from their effect on the 
membrane potential. The excitatory/inhibitory actions switch during different 
developmental stages. In embryonic neurones, the cytoplasmic concentration of 
Cl- is high, therefore the Cl- equilibrium potential is more positive than the 
membrane potential. Opening of GABA/glycine-activated Cl- channels leads to Cl- 
efflux and membrane depolarisation, thus producing an excitatory response 
(Owens et al, 1996). On the other hand, in adult neurones, due to actions of the 
K+-Cl- cotransporter (KCC2), [Cl-]i is reduced making a Cl- equilibrium potential 
more negative than the resting potential. Cl- influx mediated by GABA/glycine 
hyperpolarises the cell and thereby inhibits neuronal activities (Wang et al, 1994).
Given the important inhibitory roles of glycine/GABA receptors in the CNS, 
malfunctions of these receptors are usually associated with neurological 
diseases. For example, mutations in the GLRA1 gene, which encodes the #1 
subunit of  glycine receptor, cause hyperekplexia (or the Startle disease). This 
condition is characterised by pronounced startle responses and hypertonia 
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(Shiang et al, 1993). Defects in GABA receptors are linked to epilepsy (Baulac et 
al, 2001) and mood disorders (Wong et al, 2003).
1.4.2.4 Calcium-activated Cl- channels (CaCC)
Existence of  Cl- currents activated by intracellular Ca2+ has been documented in 
a wide range of  cells, from epithelia to neurones (see review  by Jentsch et al, 
2002). However, the molecular identity of  responsible channels remained largely 
unknown until recently due to the lack of  specific pharmacological tools. The 
following few  candidates have been suggested to be CaCCs although 
controversies over their proposed role still exist.
Firstly, the bovine CLCA1 gene was cloned for the putative CaCC, followed by 
cloning of  its analogues in other species (Cunningham et al, 1995). A problem of 
the CLCA-mediated currents is that, in patch-clamp recordings, a very high 
concentration of  Ca2+ (2 mM) in the pipette solution is required to evoke Cl- 
currents (Gandhi et al, 1998; Gruber et al, 1998), making this current 
physiologically irrelevant. It cannot be ruled out that CLCA may be a regulator of 
the CaCC, rather than the CaCC itself. 
A four membered family of Bestrophines (BEST1-BEST4) has been proposed to 
be the CaCC. However, the function of  bestrophines is very controversial. For 
example, the mouse BEST2 was thought to be the CaCC in olfactory epithelium 
(Pifferi et al, 2006) but other studies cannot locate the gene in this tissue (Bakall 
et al, 2008). The role of mBEST2 as a CaCC in other tissues was disputed by the 
knock-out animal data showing the unaffected CaCC currents (Pifferi et al, 2009). 
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More recently, three research groups cloned TMEM16A (also known as 
anoctamin-1) almost at the same time and proposed it as a strong candidate for 
CaCC (Caputo et al, 2008; Schroeder et al, 2008; Yang et al, 2008). Three 
methods were employed to identify the CaCC role of TMEM16A. Caputo et al 
(2008) performed genomic analysis to detect membrane proteins that interact 
with interleukin-4 (IL-4) as IL-4 is shown to increase the CaCC activity. Jan’s 
group (Schroeder et al, 2008) used the Axolotl oocyte expression, which lacks 
endogenous CaCC activity, for functional cloning of  TMEM16A from an Xenopus 
oocyte library. Oh and colleagues (Yang et al, 2008) searched database for 
channel- like proteins with multiple transmembrane domains and identified 
TMEM16A with 8 putative transmembrane segments and cytosolic N- and C- 
termini. Data from these three independent studies provide compelling evidence 
to support TMEM16A as the CaCC, with regards to its similarity to the native 
CaCC currents, reduction in CaCC currents following RNA interference against 
TMEM16A, its permeation properties and pharmacological features.
1.4.2.5 Volume regulated anion channels (VRAC)
Cells regulate their volume in response to various external challenges. Upon cell 
swelling or shrinkage, cells regulate their volume to maintain its normal range. 
These processes are called regulatory volume decrease (RVD) or regulatory 
volume increase (RVI), respectively. Although the exact mechanism is unclear, 
cell swelling upon hypotonic shock induces a Cl- current (ICl, swell), or known as the 
“swelling current”. 
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Different names have been given to the channel that mediates the swelling 
current. Strange and co-workers named this channel “volume-stimulated 
osmolyte and anion channel” (VSOAC) (Jackson et al, 1994). Okada used the 
name “volume expansion-sensing outwardly rectifying Cl- channel” (VSOR) in his 
review  (Okada, 1997). More recently, the name “volume-regulated anion 
channel” (VRAC) is more frequently used by the ion channel community. All these 
names refer to the same unknown channel as discussed in this section. 
The VRAC-mediated current is anion-selective and its anion preference follows 
SCN- > I- > Br- > Cl- > F- > gluconate (Kubo and Okada, 1992) (known as 
“Eisenman’s sequence I”). The currents show  moderate outward rectification and 
time-dependent inactivation at positive potentials (Jackson and Strange, 1995). 
Extracellular ATP has been shown to inhibit the ICl, swell with more pronounced 
effect on the outward current. This inhibitory effect by ATP was seen from both 
whole-cell (Tsumura et al, 1996) and single channel (Jackson and Strange, 1995) 
recordings. 
The molecular identity of VRAC remains a mystery, partly due to the lack of 
specific blockers or activators of  the channel. Candidate genes for this channel 
have been proposed and subsequently disputed. First, P-glycoprotein (MDR1), 
an ABC transporter, was suggested to mediate the ICl, swell as over-expression of 
the MDR1 gene increased swelling-induced Cl- currents (Valverde et al, 1992). 
However, other groups reported that the MDR1 expression was unrelated to ICl, 
swell (see review  by Idriss et al, 2000). Then, pICln was identified as the VRAC by 
expression cloning (Paulmichl et al, 1992). The major issue for pICln being the 
VRAC is that no transmembrane domains can be found by hydropathy analysis, 
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therefore suggesting pICln is more likely to be an intracellular protein 
(Krapivinsky et al, 1994). Finally, ClC-3 was proposed as a candidate for VRAC 
(Duan et al, 1997) but in the ClC-3 deficient mice, the volume sensitive Cl- 
currents were not affected (Stobrawa et al, 2001). To conclude, the molecular 
basis of VRAC has still not been established and it cannot be excluded that 
VRAC may have a diverse molecular profile. 
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1.5 Aims of the study
This study will focus on investigating the biophysical and pharmacological 
properties of  Panx1, a protein shown to be associated with the P2X7 receptors. I 
aim to provide answers to whether, and how, Panx1 may function as an ion 
channel independently of the P2X7R.
The biophysical characterisations of  Panx1 will include the analysis of the 
following aspects. First, basic features of Panx1 currents. The current-voltage 
relationship of  the Panx1 currents will be examined using whole-cell patch-clamp 
techniques. In addition, mechanisms of modulations of the Panx1 currents will be 
explored. Second, the permeation properties of  Panx1. Ion substitution 
experiments will be performed to investigate the selectivity of Panx1. I will carry 
out site-directed mutagenesis, aiming to identify the regions of Panx1 that may 
be responsible for its ion selectivity. Third, single channel properties will be 
investigated to provide further evidence to conclude whether Panx1 is an ion 
channel, or a hemichannel as conventionally thought. 
The second aim of  this project is to study the pharmacology of Panx1. The 
following four groups of  chemicals will be tested using electrophysiological 
approaches: (1) classical hemichannel/gap junction blockers; (2) blockers for the 
P2X7 receptors; (3) agonists of the P2X7 receptors and their analogues and (4) 
chloride channel inhibitors. It is expected that pharmacological data will not only 
provide insight into novel Panx1 antagonists but also contribute to the 
understanding of the properties of Panx1 as an ion channel.
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Chapter 2 Materials and Methods
2.1 Materials
2.1.1 Reagents
General salts were purchased from Sigma-Aldrich, Poole, UK, unless otherwise 
stated. Details of  agonists, antagonists and other reagents are summarised in 
Table 2.1.1.
Table 2.1.1 Agonists, antagonists and other reagents
Name Abbreviation Supplier
Adenosine 5"-triphosphate ATP Sigma-Aldrich, Poole, UK
2"(3")-O-(4-Benzoylbenzoyl)
adenosine 5"-triphosphate BzATP Sigma-Aldrich, Poole, UK
Adenosine 5"-diphosphate ADP Sigma-Aldrich, Poole, UK
Adenosine 5"-monophosphate AMP Sigma-Aldrich, Poole, UK
Adenosine - Sigma-Aldrich, Poole, UK
Uridine 5"-triphosphate UTP Sigma-Aldrich, Poole, UK
Guanosine 5"-triphosphate GTP Sigma-Aldrich, Poole, UK
Pyrophosphate PPi Sigma-Aldrich, Poole, UK
1-[6-((17-3-methoxyestra-1,3,5
(10)-trien-17-yl)amino)
hexyl]-1H-pyrrole-2,5-dione
U73122 Merck Chemicals, Nottingham, UK
1-[6-((17-3-methoxyestra-1,3,5
(10)-trien-17-yl)amino)
hexyl]-2,5-pyrrolidinedione
U73343 Merck Chemicals, Nottingham, UK
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Name Abbreviation Supplier
Carbenoxolone CBX Sigma-Aldrich, Poole, UK
Disodium 4,4- 
diisothiocyanatostilbene-2,2-
disulfonate
DIDS Sigma-Aldrich, Poole, UK
5-nitro-2-(3-phenylpropylamino)
benzoic acid NPPB Sigma-Aldrich, Poole, UK
Disodium 4-acetamido-4- 
isothiocyanato-stilben-2,2-
disulfonate
SITS Sigma-Aldrich, Poole, UK
Indanyloxy-acetic acid 94 IAA-94 Sigma-Aldrich, Poole, UK
Flufenamic acid FFA Sigma-Aldrich, Poole, UK
Niflumic acid NFA Sigma-Aldrich, Poole, UK
Mefloquine MFQ Sigma-Aldrich, Poole, UK
Probenecid - Sigma-Aldrich, Poole, UK
4-(2-Butyl-6,7-dichloro-2-
cyclopentyl-2,3-dihydro-1-
oxo-1H-inden-5-yl)oxybutanoic 
acid
DCPIB Tocris Bioscience, Bristol, UK
Glybenclamide - Sigma-Aldrich, Poole, UK
Diphenylamine-2-carboxylate DPC Merck Chemicals, Nottingham, UK
Anthracene-9-carboxylic acid 9-AC Sigma-Aldrich, Poole, UK
Phloretin - Sigma-Aldrich, Poole, UK
Fluoxetine - Sigma-Aldrich, Poole, UK
Tamoxifen - Sigma-Aldrich, Poole, UK
Ethidium bromide EtBr Sigma-Aldrich, Poole, UK
2-{[2-(2-{5-[bis(carboxymethyl) 
amino]-2-methylphenoxy}
ethoxy)-4- (2,7-difluoro-6-
hydroxy-3-oxo-3H- xanthen-9-
yl)phenyl](carboxymethyl) 
amino}acetic acid
Fluo-4 AM Invitrogen, Paisley, UK
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Name Abbreviation Supplier
Acetoxymethyl 2-[5-[bis
[(acetoxymeth oxy-oxo-methyl)
methyl]amino]-4-[2-[2- [bis
[(acetoxymethoxy-oxo-methyl) 
methyl]amino]-5-methyl-
phenoxy] ethoxy] benzofuran-2-
yl]oxazole-5-carboxylate
Fura-2 AM Invitrogen, Paisley, UK
2.1.2 Buffers and solutions
Recipes for standard buffers and solutions are presented in Table 2.1.2. 
Modifications of standard solutions are detailed where they are used. 
Table 2.1.2 Buffers and solutions
Name Components
Fluo-4/Fura-2 loading buffer 8 g of NaCl
0.2 g of KCl
1.44 g of Na2HPO4
0.24 g of KH2PO4
pH to 7.4 with HCl
adjust to 1L with H2O
Fluo-4/Fura-2 loading buffer 136 mM NaCl
20 mM HEPES
5.5 mM Glucose
1.2 mM KH2PO4
1.2 mM MgSO4
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Name Components
Fluo-4/Fura-2 loading buffer (continued)
5 mM NaHCO3
1.8 mM KCl
1.2 mM CaCl2
0.2 mM EGTA
pH to 7.4 with NaOH
Standard external solution for 147 mM NaCl
patch clamp recordings 10 mM HEPES
13 mM Glucose
2 mM KCl
2 mM CaCl2
1 mM MgCl2
pH to 7.3 with NaOH
osmolarity: ~ 300 mOsm
Standard internal solution for 147 mM NaCl
patch clamp recordings 10 mM HEPES
10 mM EGTA
pH to 7.3 with NaOH
osmolarity: ~ 300 mOsm
2.1.3 Cell lines
Cell lines used in this study are presented in Table 2.1.3.
80
Table 2.1.3 Cell lines
Name ATTC® number Description
HEK 293 cells CRL-1573 Derived from human embryonic kidney
2.1.4 Cell culture media
Cell culture media used in this study are summarised in Table 2.1.4.
Table 2.1.4 Cell culture media
Name Components
Dulbecco's modified Eagle's Contains high D-glucose, sodium
medium / Ham's nutrient mixture F12 pyruvate and phenol red;
(1:1) buffered with HEPES;
(Invitrogen, Paisley, UK) supplemented with 2 mM L-glutamine
and 10% foetal calf serum
Fluo-4/Fura-2 loading buffer Contains sodium bicarbonate,
hypoxanthine, thymidine, sodium 
pyruvate, L-glutamine, trace elements
and growth factors;buffered with
buffered with HEPES
2.1.5 Enzymes 
Enzymes used in this study are presented in Table 2.1.5.
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Table 2.1.5 Enzymes
Name Supplier
Trpsin Invitrogen, Paisley, UK
Pfu DNA polymerase Bioline, London, UK
Taq DNA polymerase Bioline, London, UK
Restriction digestion enzyme XbaI New England Biolabs, Hitchin, UK
Alkaline phosphatase New England Biolabs, Hitchin, UK
T4 DNA ligase Bioline, London, UK
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2.2 Methods
2.2.1 Maintenance of cell lines 
The human embryonic kidney (HEK) 293 cells (American Type Culture 
Collection, Teddington, UK) were cultured in growth medium consisting of D-
MEM:F-12 (1:1) supplemented with 10% of foetal calf  serum (FCS) under a 
humidified atmosphere of 5% CO2 at 37 °C. 
To subculture the cells, 1.5 ml of 1X trypsin-EDTA (0.25%) was added to a T25 
flask (IWAKI, P&R Labpak, St Helens, UK) to dissociate the cells from the wall of 
the flask. Cells were incubated in trypsin at 37°C for 3 to 5 minutes before being 
harvested into a 10 ml centrifuge tube containing 5 ml of growth medium. Cells 
were then centrifuged at 2,500 rpm for 4 minutes. The cell pellets were 
resuspended in fresh growth medium before seeded into a new flask.
2.2.2 Transfection of HEK 293 cells
Lipofectamine 2000 reagent (Invitrogen, Paisley, UK) was used according to 
manufacturer’s instructions for transfecting HEK 293 cells.  Briefly, 1 µg of  the 
plasmid of interest and 0.1 µg of  the plasmid encoding e-GFP (where necessary) 
were mixed in 100 µl of  Opti-MEM.  3 µl of lipofectamine was diluted in 100 µl of 
Opti-MEM in a separate tube.  The DNA- and the lipofectamine- containing Opti-
MEM were mixed and kept at room temperature for 20 minutes before being 
added to 35 mm petri dishes (IWAKI, P&R Labpak, St Helens, UK) containing 
83
HEK cells (90~100% confluent).  Cells were incubated in the DNA-lipofectamine 
medium for a period of 4 to 24 hours.  Transfected cells were harvested by 
incubation with 1 ml of 1X trpsin for 2 minutes, then centrifuged at at 2,500 rpm 
for 4 minutes in growth medium (D-MEM:F-12). The cell pellets were 
resuspended in 3 ml of  fresh medium. Approximately 103 of  cells were plated on 
to 13 mm borosilicate glass coverslips (No 1 thickness, VWR International, 
Lutterworth, UK). 
2.2.3 Site-directed mutagenesis
Point mutations were constructed based on a plasmid containing the wild type 
mouse Panx1 with a C-terminal Myc tag. Mutations were introduced by a 
polymerase chain reaction (PCR) using primers containing mis-matched base 
pairs at desired positions. The primers also contained 9 extra nucleotides (i.e. 
corresponding to 3 amino acids) that were complementary to the wild type 
sequence at each side of the mutation. These “mutation” primers were paired 
with either a forward universal primer (“T7”) that matched the sequence of  the 
vector that was upstream to the cDNA of  wild type mPanx1 or a reverse universal 
primer (“BGHR”) matching the downstream sequence to the cDNA. Two 
fragments were produced from two separate PCR reactions and each of  the PCR 
products contained half  of the mutated mPanx1 sequence. In a 50 µl PCR 
reaction, 100 ng of  the wild type template (100 ng/µl) was mixed with 2 µl of each 
forward and reverse primers (10 µM), 1 µl of dNTPs (10 mM), 1 µl of Pfu 
polymerase (2.5 U/µl), 5 µl of  10 X Pfu buffer and 38 µl of ultrapure H2O. The 
PCR reaction was:
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94 °C, 5 min
(94 °C, 30 s; 60 °C, 30 s; 72 °C, * s) X 20 cycles
72 °C, 7 min
4 °C, hold
* The extension time was dependent on the 
length of  fragment to be amplified, usually 2 
min/kb.
After gel purification, a fusion PCR was performed to fuse the two PCR products 
previously made to obtain the full-length mutated mPanx1 cDNA. The fusion PCR 
reaction was as follows:
94 °C, 5 min
(94 °C, 30 s; 54 °C, 30 s; 72 °C, 3.5 min) X 25 cycles
72 °C, 7 min
4 °C, hold
The product of the fusion PCR was purified using the QIAquick PCR purification 
kit (Qiagen, Crawley, UK) and digested with XbaI to generate “sticky” ends (the 
insert) for ligation. The blank pcDNA3.1 vector was also digested with XbaI and 
was ligated with the insert using T4 DNA ligase at room temperature over night. 
The ligated new  plasmid was then transformed into JM109 competent bacterial 
cells. Single colonies growing under the selection pressure of  ampicillin were 
selected and screened by PCR using a forward primer detecting the middle of the 
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mPanx1 cDNA and a universal reverse primer matching the downstream vector 
sequence (“BGHR”). The screening PCR reaction was:
 
94 °C, 5 min
(94 °C, 30 s; 55 °C, 30 s; 72 °C, 1 min) X 30 cycles
72 °C, 10 min
4 °C, hold
 
Positive colonies were amplified and the plasmids were harvested by the 
QIAprep Spin miniprep kit (Qiagen, Crawley, UK). Mutations were verified by 
sequencing (Beckham Coulter Genomics, Takeley, UK). 
2.2.4 Whole-cell patch clamp recordings
For electrophysiology experiments, cells plated on 13 mm coverslips were placed 
in a bath chamber on the stage of  an Axiovert 100 inverted microscope (Carl 
Zeiss, Welwyn Garden City, UK) and perfused with extracellular solution at a rate 
of approximately 1 ml/min. The composition of standard extracellular solution is 
presented in Table 2.1.2 whereas any other non-standard external solutions are 
detailed in the Results chapters.  Drugs were applied via a rapid solution changer 
system (RSC-200, Bio-logic Science Instruments, Grenoble, France).  Micro-
electrodes were prepared by pulling thin wall borosilicate glass capillaries (1.5 
mm outside diameter with filament, World Precision Instruments, Stevenage, UK) 
using a two-step electrode puller (Narishige, Tokyo, Japan).  The electrode was 
filled with intracellular solution (see Table 2.1.2 for the standard intracellular 
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solution and the Results chapter for others) and had a series resistance of 3 ~ 6 
m*.
Whole cell recordings were made using an EPC-9 patch clamp amplifier and 
Pulse software (HEKA, Lambrect, Germany) at room temperature (20 ± 3 °C). An 
Ag-AgCl reference electrode (World Precision Instruments, Stevenage, UK) was 
immersed in the extracellular solution. In experiments where extracellular Cl- 
concentrations were changed, the reference Ag-AgCl pellet was embedded in an 
agar bridge containing 3 M KCl to minimise offset potentials. 
The micro-electrode was positioned onto the surface of  a cell with the aid of a 
Mitutoyo three-dimensional micromanipulator (Intracel, Royston, UK), and cell 
membrane was sealed within the tip of the electrode by a slight suction applied 
using a 1 ml syringe. The fast capacitance transients caused by the electrode 
were compensated. The holding potential was set to -60 mV, which is close to the 
resting potential of the cell. After a seal resistance of at least 1 giga-ohm was 
achieved, a second suction was applied to obtain whole-cell configuration. The 
slow  capacitance transients were compensated and the membrane capacitance 
and series resistance were recorded. The capacitance of a typical HEK cell 
varied between 5 and 20 pF, and any cell with a series resistance larger than 15 
M* was discarded.
Current-voltage relationship experiments were performed using either a 100 ms 
ramp protocol ranging from -120 mV to +70 mV, or a 300 ms voltage steps 
protocol from -120 mV to +70 mV with increments of 20 mV. All traces were 
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analysed by PulseFit software (HEKA, Lambrect, Germany) and then exported to 
Axograph 4.8 (Axograph Scientific, Sydney, Australia). KaleidaGraph (Synergy 
Software, Reading, PA, USA) was used to plot the traces and create image files 
for figures. 
2.2.5 Calcium assay on FlexStation 3
Cells were plated in a 96-well black assay plate with clear bottom (Corning, 
Lowell, MA, USA) and cultured over night to reach 90~100% confluency. For 
calcium assay, cells were preincubated with 4 mM Fura-2 AM or 1 mM Fluo-4 AM 
(Invitrogen, Paisley, UK) at 37 ºC for 30 minutes. Prior to recording, the 
fluorescent calcium indicator was removed and replaced with the standard 
extracellular solution (see Table 2.1.2). Fluorescence was recorded by an 
automatic fluorescence plate reader, FlexStation 3 (Molecular Devices, 
Sunnyvale, CA, USA) over 5 to 10 minutes.  The dual excitation for Fura-2 was 
set to 340 nm and 360 nm and the emission was 510 nm. The excitation and 
emission Fluo-4 were 480 nm and 510 nm, respectively. Agonists were added 
into the wells automatically by the machine at designated time points whereas 
any antagonists were added to the wells before recording started.  [Ca2+]i was 
expressed as the ratio of the emission intensities for 340 and 360 nm for Fura-2 
recordings or as arbitrary fluorescent units for Fluo-4 recordings. Data were 
exported to Excel (Microsoft, Redmond, WA, USA) and plotted using 
KaleidaGraph (Synergy Software, Reading, PA, USA). 
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2.2.6 Measurement of dye uptake 
Ethidium bromide (EtBr) uptake was performed using a Nikon Eclipse TE300 
confocal microscope (Nikon, Kingston, UK) with excitation and emission filters at 
543 nm and 590 nm for a laser beam (Uniphase, Model 1676-9999, Witney, UK). 
Cells (usually HEK cells over-expressing rP2X7, unless otherwise stated) were 
plated on coverslips (13 mm diameter) at about 80% confluency. Cells were were 
perfused with the standard extracellular solution (see Table 2.1.2) containing the 
same concentration of EtBr throughout the recording. Basal level of  fluorescence 
was recorded for 1 min before agonists (5 mM ATP or 100 µM BzATP) were 
applied through a perfusion system. Fluorescence was recorded at intervals of  5 
s for 10 min, during which saturation of dye uptake was reached. For each 
experiments, regions-of-interest (ROIs) were drawn to approximately 30 cells to 
obtain the average maximum values and rates of dye uptake. 
2.2.6 Data analysis and statistics
Data were analysed in KaleidaGraph (Synergy Software, Reading, PA, USA) and 
expressed as mean ± standard error of the mean (s.e.m.)  Error bars in figures 
repsent s.e.m.  Statistical difference between means was assessed using 
unpaired Student’s t-tests in KaleidaGraph, a p value of 0.05 or less was 
considered statistically significant.
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Chapter 3 Paper I
Identification of the amino acid residues in the extracellular domain of the 
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Identification of the amino acid residues in the
extracellular domain of rat P2X7 receptor involved
in functional inhibition by acidic pH
X Liu1, W Ma2, A Surprenant2 and L-H Jiang1
1Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK, and 2Faculty of
Life Sciences, University of Manchester, Manchester, UK
Background and purpose: P2X7 receptors are potently inhibited by extracellular acidification. The underlying molecular basis
remains unknown. This study aimed to examine the role of extracellular histidine, lysine, aspartic acid and glutamic acid
residues in the functional inhibition of rat P2X7 receptors by acidic pH.
Experimental approach: We introduced point mutations into rat P2X7 receptor by site-directed mutagenesis, expressed wild
type (WT) and mutant receptors in human embryonic kidney (HEK293) cells and, using patch clamp recording, characterized
the effects of acidic pH on BzATP [2′-3′-O-(4-benzoylbenzoyl) adenosine 5′-triphosphate]-evoked ionic currents.
Key results: Reducing extracellular pH, that is, increasing extracellular proton concentrations, inhibited BzATP-evoked currents
in cells expressing WT P2X7 receptors, with IC50 value (half-maximal antagonist or inhibitor concentration) for protons of
0.2 mmol·L-1. The major effect of acidification was suppression of the maximal current response without altering the agonist
sensitivity. Five residues in the receptor extracellular domain (His85, Lys110, Lys137, Asp197 and His219) were mutated to alanine and
current inhibition by protons assessed. Compared with WT, the H85A, H219A, K137A mutants were two- to threefold more
sensitive, whereas the K110A and D197A mutants were 2.5- and 9-fold less sensitive. Double-alanine substitution of Lys110 and
Asp197 resulted in 23-fold decreased sensitivity to inhibition by protons. Furthermore, charge neutralization (K110M, K110F,
D197N and D197F), but not charge conserving mutation (K110R and D197E), attenuated the inhibition of currents by protons.
Conclusions and implications: Functional inhibition of rat P2X7 receptors by acidic pH was variably affected by the extra-
cellular His85, Lys110, Lys137, Asp197 and His219 residues, with the Asp197 residue being most critical for this inhibition.
British Journal of Pharmacology (2009) 156, 135–142; doi:10.1111/j.1476-5381.2008.00002.x; published online 5
December 2008
Keywords: acidification; at P2X7 receptor; heterologous expression; mutagenesis
Abbreviations: BzATP, 2’-3’-O-(4-benzoylbenzoyl) adenosine 5’-triphosphate; HEK293, human embryonic kidney cell line;
EC50, half-maximal agonist concentration; IC50, half-maximal antagonist or inhibitor concentration
Introduction
P2X receptors are a family of ATP-gated ion channels formed
by assembly of homo/hetero-trimers from seven subunits
(P2X1–7) (North, 2002; nomenclature conforms to Alexander
et al., 2008). Each subunit has a large extracellular domain
flanked by two transmembrane segments (TM1 and TM2),
and intracellular N- and C-termini. The P2X7 receptor is the
last and also the unique member of the P2X receptor family,
as it not only forms a Ca2+-permeable cationic channel that is
opened by brief application of agonist but also induces for-
mation of pores passing large inorganic molecules up to
900 Da in response to sustained stimulation (Surprenant
et al., 1996; Rassendren et al., 1997). P2X7 receptors are pre-
dominantly localized on immune cells such as macrophages,
mast cells, monocytes and lymphocytes, and also on non-
neuronal cells (such as microglia and astrocytes) in the brain
and spinal cord (Surprenant et al., 1996; Collo et al., 1997;
Duan and Neary, 2006). There is compelling evidence that
P2X7 receptors play crucial roles in immune responses and
inflammation (MacKenzie et al., 2001; Solle et al., 2001;
Labasi et al., 2002; Ferrari et al., 2006), neuron-glia communi-
cation (Zhang et al., 2007), inflammatory and neuropathic
pain (Chessell et al., 2005; Honore et al., 2006), neuronal
damage (Choi et al., 2007) and autoimmune encephalomyeli-
tis (Matute et al., 2007).
Extracellular acidosis occurs at sites of inflammation and
infection, and also in injured or malignant tissues (Edlow and
Sheldon, 1971; Nielson et al., 1981; Simmen and Blaser, 1993)
or in the surroundings of neurons undergoing intense activa-
tion (Chesler and Kaila, 1992). P2X receptors are functionally
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regulated by acidic pH and the consequences depend on
the receptor subtypes. Thus, reduction in extracellular pH
facilitates P2X2 and P2X2/3 receptors but inhibits P2X1, P2X3,
P2X4 and P2X7 receptors (King et al., 1996; 1997; Li et al.,
1996; 1997; Stoop et al., 1997; Wildman et al., 1997; 1998;
1999a,b; Virginio et al., 1997). Site-directed mutagenesis
studies have identified receptor-specific histidine (His) resi-
dues in the extracellular domain of the receptors that medi-
ates functional modulation of P2X2 (His319), P2X3 (His206) and
P2X4 (His286) receptors (Clarke et al., 2000; Clyne et al., 2002;
Gerevich et al., 2007). However, the extracellular histidine
residues seem to play no or only a minor role in inhibiting
P2X7 receptors (Acuna-Castillo et al., 2007). It is known that
lysine (Lys), aspartic acid (Asp) and glutamic acid (Glu) resi-
dues, as well as histidine, can coordinate proton binding and
mediate functional modulation of pH-sensitive ion channels
and receptors (Rho and Park, 1998; Wilkins et al., 2005; Mott
et al., 2008). There are several such residues that are specifi-
cally present in the extracellular domain of P2X7 receptors.
This study, combining site-directed mutagenesis and patch
clamp current recording, examined the role of these residues
in the rat P2X7 receptor (Fig. 1). We showed that Lys110 and
particularly Asp197 were important in the functional inhibi-
tion of rat P2X7 receptor by acidic pH.
Methods
Constructs, cell culture and transfection
Alanine mutations in rat and mouse P2X7 receptors tagged
with a C-terminal EYMPME epitope were introduced by site-
directed mutagenesis and confirmed by sequencing. Human
embryonic kidney (HEK293) cells were used to express P2X7
receptors. Cell maintenance and transfection were carried out
as described previously (Liu et al., 2008).
Patch clamp current recording and dye uptake assay
Whole-cell patch clamp recording was performed using an
Axopatch 200B amplifier (Axon) at room temperature as
described previously (Liu et al., 2008). Internal solution con-
tained (in mmol·L-1) 145 NaCl, 10 HEPES and 10 EGTA, pH
7.3, and standard external solution contained (in mmol·L-1)
147 NaCl, 2 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and 13 glucose.
External solutions were adjusted to the desired pH with con-
centrated NaOH or HCl, with pH 7.3 for standard external
solution. Agonist application or change in external pH was
via a RSC160 system (Biologic, France). BzATP [2′-3′-O-(4-
benzoylbenzoyl) adenosine 5′-triphosphate] concentrations
used, except specified, are close to EC50 for each receptor (Liu
et al., 2008), and listed in Table 1.
Ethidium dye uptake assay was performed using a Nikon
confocal microscope with excitation/emission at 543/
590 nm. Prior to recording, cells were perfused with
25 mmol·L-1 ethidium bromide for 5 min in external solutions
at the indicated pH. Fluorescence was recorded at 5 s intervals
for 1 min, before superfusion application of 100 mmol·L-1
BzATP. Fluorescence was measured over another 9 min,
during which it reached the maximum. For each set of experi-
ments, 30–50 isolated cells were analysed to obtain
the average maximum values and the rates of dye uptake
(Pelegrin and Surprenant, 2007).
Data analysis
Data are presented as mean ! SEM. The mean EC50 values for
BzATP were obtained by least square fitting the data from each
cell to the Hill equation: I/Imax = 100/(1 + (EC50/[BzATP])n),
where I represents currents evoked by BzATP expressed as % of
the maximal current, Imax, for each cell, EC50 is the concentra-
tion evoking half of maximal current, and n is the Hill coef-
ficient. Similarly, the mean IC50 values were determined by
fitting the data from each cell to I/I0 = l00/(1 + ([proton]/
IC50)n), where I is the agonist-evoked currents in solutions
with indicated pH or proton concentrations, expressed as %
of the maximal current, I0, for each cell, IC50 is the concen-
tration inhibiting half of maximal current, and n is the Hill
coefficient. The smooth curves shown in the figures were
derived by fitting the mean data. Curve fit was carried out
using Origin program (OriginLab, Northampton, MA). Com-
parison was made using Student’s t-test.
Materials
All chemicals, including BzATP and ethidium bromide, were
purchased from Sigma, culture media and transfection
reagent (lipofectamine2000) from Invitrogen and HEK293
cells from American Type Culture Collection.
Results
Characterization of effects of extracellular pH on WT rat
P2X7 receptor
Figure 2A shows a set of representative inward current record-
ings evoked by BzATP in a cell expressing wild-type (WT) rat
P2X7 receptor in extracellular solutions with pH values
ranging from pH 8.5 to pH 5.5. Currents were slightly
increased by mild alkalinization (pH 8.0–8.5), compared with
control pH 7.5. Currents were progressively attenuated by
reducing pH from 7.5 to 5.5 and almost completely abolished
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Figure 1 Amino acid residues in the extracellular domain of the rat
P2X7 receptor. Schematic presentation of the rat P2X7 receptor
subunit, in which the 10 conserved cysteine residues, indicated in
open circles, are thought to form disulfide bonds. The residues in the
extracellular domain investigated in this study are marked as filled
circles.
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by strong acidification to pH 5.5. The onset of inhibition was
fast, as a steady state was readily reached within 1–2 s
(Fig. 2A). Simultaneous washing of BzATP and changing back
to the control pH (7.5) resulted in strong rebound currents
(indicated by arrows in Fig. 2A), indicating that the reversal of
inhibition was rapid, or at least faster than dissociation of
BzATP from the receptor. The concentration–response curve
yielded an IC50 value for protons of 0.2 ! 0.02 mmol·L-1
(n = 10) (Fig. 2B and Table 1).
Effects of acidic pH on rat and mouse WT and mutant
P2X7 receptors
We examined five histidines, three glutamic acids, two aspar-
tic acids and four lysines in the extracellular domain of
rat P2X7 receptor (Fig. 1). Although Asp156 is replaced with
glutamic acid in human P2X7 receptors, and Glu115 and Asp197
are replaced with valine and histidine respectively in mouse
P2X7 receptors, these residues are specific and conserved in
human, rat and mouse P2X7 receptors. While alanine substi-
tution of two residues (Lys54 and Asp156) led to complete loss of
function, all 12 other alanine mutants were functional and
showed similar agonist sensitivity to that of the WT receptor,
with the exception of the H201A mutant that was approxi-
mately fourfold less sensitive (Liu et al., 2008).
To examine the role of these residues in functional inhibi-
tion by acidic pH, we used BzATP, at concentrations approxi-
mating to the EC50 for each receptor, and compared BzATP-
evoked currents in extracellular solutions with pH 8.0 and pH
6.5 (Fig. 3A). There was no significant difference in the inhi-
bition of BzATP-evoked currents for seven out of the 12
mutants (Fig. 3B). However, the degree of inhibition was
significantly increased by mutating His85, His219 or Lys137 to
alanine, and markedly decreased by substituting Lys110 and
particularly Asp197, with alanine (Fig. 3B). These results
suggest that the sensitivity of rat P2X7 receptors to protons
involves these five residues, among which Asp197 is most criti-
cal. We also carried out similar experiments on WT mouse
P2X7 receptors, where the Asp197 in human P2X7 receptors is
replaced by His197, and the corresponding mutant H197A
Table 1 Effects of extracellular acidic pH on wild type (WT) and mutant P2X7 receptors
Receptors BzATP used (mmol·L-1) Proton IC50 (mmol·L-1) nH Cell No.
WT 50 0.17 ! 0.02 1.37 ! 0.07 10
H62A 50 0.15 ! 0.03 1.14 ! 0.14 5
H85A 50 0.06 ! 0.01* 1.55 ! 0.03* 4
H201A 50 0.11 ! 0.01 1.19 ! 0.01* 3
H219A 30 0.05 ! 0.004* 1.69 ! 0.17 3
H267A 30 0.11 ! 0.002 1.91 ! 0.26 3
E70A 50 0.10 ! 0.01 2.12 ! 0.25 3
K110A 100 0.52 ! 0.11** 1.15 ! 0.18 7
K110R 30 0.20 ! 0.01 1.16 ! 0.07 3
K110M 50 0.42 ! 0.07* 1.35 ! 0.45 4
K110F 100 1.13 ! 0.12* 0.71 ! 0.04** 4
E115A 50 0.14 ! 0.05 1.22 ! 0.09 3
K137A 30 0.09 ! 0.003* 1.76 ! 0.03** 3
K145A 200 0.12 ! 0.01 1.29 ! 0.08 3
D197A 100 1.76 ! 0.45** 0.90 ! 0.06** 8
D197E 30 0.14 ! 0.01 1.29 ! 0.14 3
D197N 50 5.51 ! 0.86** 1.01 ! 0.29 3
D197F 10 0.67 ! 0.07* 1.03 ! 0.07* 4
E255A 30 0.12 ! 0.02 1.20 ! 0.06 3
D197A/K110A 200 4.71 ! 1.02** 1.12 ! 0.15 7
Data shown in the table are the mean ! SEM results from the numbers of cells studied (cell No.). *P < 0.01, **P < 0.001 compared with WT.
A, alanine; BzATP, 2′-3′-O-(4-benzoylbenzoyl) adenosine 5′-triphosphate; E, glutamic acid; D, aspartic acid; F, phenylalanine; H, histidine; IC50, half-maximal
antagonist or inhibitor concentration; K, lysine; M, methionine; N, asparagine; R, arginine.
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Figure 2 Concentration-dependent effect of protons on rat P2X7
receptor-mediated currents. A. Representative BzATP-evoked currents
in extracellular solutions with pH ranging from 8.5 to 5.5 in a cell
expressing wild-type rat P2X7 receptors. The arrows denote the
rebound currents upon simultaneous washout of BzATP and change
back to control pH 7.5. B. Proton concentration–current relationship
curve, derived from data obtained from experiments shown in (A).
n = 3–5 for each data point. BzATP, 2′-3′-O-(4-benzoylbenzoyl)
adenosine 5′-triphosphate.
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receptor. The BzATP-evoked currents for WT mouse receptors
were strongly inhibited by pH 6.5, and substitution of His197
with alanine abolished this inhibition (Fig. 3C,D).
We next constructed full proton concentration–current
response relationship curves. Figure 4 illustrates BzATP-evoked
currents in the extracellular solutions with pH ranging from
7.5 to 5.5 forWT, K110A andD197Amutant rat P2X7 receptors.
The IC50 values for protons were 0.5 ! 0.1 mmol·L-1 and 1.8 !
0.5 mmol·L-1 for the K110A and D197A mutants, representing
a 2.5-fold decrease and a ninefold decrease in the sensitivity
to protons. In contrast, mutation of His85, His219 or Lys137
rendered the resultant mutant receptors threefold, 3.4-fold
and twofold more sensitive (Table 1). This Table also shows
IC50 and Hill coefficient values obtained from these types of
experiments at all rat P2X7 mutants examined in this study.
We further generated a double mutant, in which both Lys110
and Asp197 residues were mutated to alanine. In standard
extracellular solution, the K110A/D197A mutant receptor
was approximately threefold less sensitive to BzATP (EC50:
187 ! 5 mmol·L-1, n = 4 for K110A/D197A; 57 ! 3 mmol·L-1,
n = 12, for WT) and the maximal currents were also signifi-
cantly augmented (3.0 ! 0.2 nA, n = 4 for K110A/D197A;
1.9 ! 0.3 nA, n = 12 for WT; P < 0.05). Nonetheless, the most
prominent change for the K110A/D197A mutant was a
23-fold reduction in the sensitivity to protons, with IC50
values of 4.7 ! 1.0 mmol·L-1 (Fig. 4B).
We also constructed BzATP concentration–current relation-
ship curves in solutions with pH 7.5 and pH 6.0 to investigate
underlying mechanisms of modulation of rat P2X7 receptors
by acidic pH. At the WT receptor, change from pH 7.5 to pH
6.0 dramatically suppressed the maximal currents (Fig. 5A)
with no significant effect on the BzATP sensitivity (Fig. 5B).
The K110A mutant was similar to WT (data not shown). In
contrast, for both the D197A and D197A/K110A mutants, the
maximal currents in pH 7.5 and pH 6.0 were not significantly
different (Fig. 5C,D), and there was very modest increase in
the sensitivity to BzATP at pH 6.0 (Fig. 5D).
Role of charge in Lys110 and Asp197 in inhibition by acidic pH of
rat P2X7 receptors
We substituted Lys110 with arginine (R), methionine (M)
or phenylalanine (F), and Asp197 with glutamic acid (E),
asparagine (N) or phenylalanine, to examine the role of
the charge. The EC50 values for BzATP were 57 ! 3 mmol·L-1
for WT (n = 12), 32 ! 3.4 mmol·L-1 for K110R (n = 5),
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77 ! 8.6 mmol·L-1 for K110M (n = 5), 95 ! 3.2 mmol·L-1 for
K110F (n = 4), 18 ! 2.5 mmol·L-1 for D197E (n = 4),
8.4 ! 0.4 mmol·L-1 for D197F (n = 4) and 57 ! 5.7 mmol·L-1 for
D197N (n = 3) respectively. Thus, both charge-conserving and
-neutralizing mutations caused less than threefold change in
the BzATP sensitivity, with an exception of the D197F muta-
tion, which resulted in a sevenfold increase in the BzATP
sensitivity. The pH sensitivity of these mutants (Table 1) was
not altered by charge-conserving mutations (K110R and
D197E), but significantly attenuated by neutralizing muta-
tions (K110M, K110F, D197F and D197N). These results,
together with those from the alanine mutations, suggest that
the charge of Lys110 and Asp197 is crucial for functional inhi-
bition of rat P2X7 receptors by protons.
Effects of acidic pH on WT and mutant rat P2X7
receptor-mediated pore formation
Finally, we examined the effect of acidic pH on pore forma-
tion in cells expressing WT, K110A and D197A mutant rat
P2X7 receptors by comparing ethidium uptake in extracellular
solutions with pH values of 7.3 and 5.5. In extracellular solu-
tion with pH 7.3, application of BzATP resulted in substantial
dye accumulation in cells expressing the WT or D197A
mutant receptors (Fig. 6A). The maximal dye uptake for the
D197A mutant was significantly reduced compared with
those for the WT. Surprisingly, there was very little dye uptake
in cells expressing the K110A mutant (Fig. 6A). Change from
pH 7.3 to pH 5.5 almost completely abolished the dye uptake
in cells expressing the WT, but had no significant effect in
cells expressing the D197A mutant (Fig. 6B,C).
Discussion
The P2X7 receptors are profoundly inhibited by extracellular
acidic pH, that is, an increase in extracellular proton con-
centrations. This study shows that acidic pH suppresses
the maximal agonist-evoked response without altering the
agonist sensitivity and several residues in the extracellular
domain are involved in the inhibition by protons. Therefore,
it provides a mechanistic and molecular understanding of the
modulation of P2X7 receptors by protons.
We have confirmed the potent inhibition of rat P2X7
receptor-mediated currents by extracellular acidification
(Fig. 2), previously reported by Virginio et al (1997). We have
also demonstrated that acidic pH has a similar inhibitory
action on mouse P2X7 receptors (Fig. 3C,D). Here we observed
that the onset of inhibition was rapid within seconds
(Fig. 2A). The reversal was also rapid; the strong rebound
currents resulting from simultaneously washing BzATP and
restoring control pH (Fig. 2A) indicate that the dissociation of
protons is at least faster than that of BzATP. The fast kinetics
suggest an extracellular action of protons on the P2X7 recep-
tors, as was proposed for the other P2X receptors (Stoop et al.,
1997). Furthermore, comparison of BzATP concentration–
current curves at pH 7.5 and pH 6.0 shows that acidic pH
mainly suppresses the maximal current response, without
significant alteration in the agonist sensitivity (Fig. 5), as
observed with the P2X4 receptor at which acidic pH is also
inhibitory (Clarke et al., 2000).
The major finding of this study is to show that Lys110 and
particularly Asp197 are important in determining the inhibi-
tion of rat P2X7 receptor by acidic pH. Extracellular histidine
residues have been identified as mediating the functional
facilitation or inhibition of P2X2, P2X3 and P2X4 receptors by
protons (Clarke et al., 2000; Clyne et al., 2002; Gerevich et al.,
2007). Consistent with a recent report (Acuna-Castillo et al.,
2007), we found that mutation of the five conserved extracel-
lular histidine residues to alanine did not attenuate the inhi-
bition by acidic pH. Interestingly, mutation of His85 and His219
instead caused a modest increase in the sensitivity to protons
(Table 1). Lysine, aspartic acid and glutamic acid residues are
also known to coordinate proton binding in pH-sensitive
channels and receptors. Indeed, alanine substitution of Lys110
and particularly Asp197 substantially reduced the inhibition of
BzATP-evoked currents (Figs 3 and 4) and dye uptake by acidic
pH (Fig. 6). Surprisingly, the K110A mutation, despite its
minimal effect on ion channel function (Liu et al., 2008;
Figs 3 and 4), led to almost complete loss of the pore forma-
tion, as indicated by the lack of dye uptake (Fig. 6A). The
reasons for this are currently unclear.
Alanine substitution of His197 in the mouse P2X7 receptor,
which corresponds to Asp197 in rat and human P2X7 recep-
tors, also prevented the inhibition of BzATP-evoked currents
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by acidic pH (Fig. 3C,D), suggesting that both aspartic acid
and histamine at this position can mediate inhibitory
modulation of P2X7 receptors by acidic pH. Moreover, sup-
pression by acidic pH of the maximal currents in BzATP
concentration–current relationship curves was largely abol-
ished in the D197A and K110A/D197A mutant rat P2X7
receptors (Fig. 5). All the results consistently support the
idea that these two residues and particularly Asp197 are criti-
cal in determining the sensitivity of rat P2X7 receptor to
inhibition by protons. The apparent pKa for rat P2X7 recep-
tors is 6.7 (Fig. 2B). The pKa for free aspartic/glutamic acid,
histidine and lysine are 4.4, 6.5 and 10 respectively (Stryer,
1995). Therefore, the sensitivity of rat P2X7 receptor to
protons is most likely to be coordinated by Asp197 and Lys110
and possibly involves His85, His219 and Lys137. In a recent
study, we have shown that Asp197 (as well as His62 and, to
less extent, His201 and His267) is important for mediating the
potent inhibition of rat P2X7 receptors by zinc and copper
(Liu et al., 2008). Taken together, these studies have revealed
that the inhibition of P2X7 receptors by protons and trace
metal ions, such as zinc and copper, engages a subset of
distinct and yet overlapping residues.
P2X7 receptors are widely and abundantly expressed in
immune cells, and have crucial roles in several immune
functions, including release of cytokines, cell proliferation
and cell death (e.g. Baricordi et al., 1999; MacKenzie et al.,
2001; Solle et al., 2001; Labasi et al., 2002; Adinolfi et al.,
2005; Tsukimoto et al., 2006). Extracellular acidosis predomi-
nantly develops at sites of inflammation, infection, tissue
injury, ischaemia and hypoxia (Edlow and Sheldon, 1971;
Nielson et al., 1981; Simmen and Blaser 1993) and, under
these circumstances, the P2X7 receptors are expected to be
functionally suppressed. It is tempting to speculate that this
tonic inhibition, which appears paradoxical, could represent
a fine-tuning mechanism, which prevents or reduces unnec-
essary cell death and meanwhile allows the physiological
events downstream of P2X7 receptor activation, such as
release of cytokines, to occur. There is increasing evidence in
support of the proposition that extracellular acidosis does
significantly affect the functions of immune cells, for
example, lymphocyte cytotoxicity and proliferation, cytok-
ine maturation and secretion (Lardner, 2001; Lang et al.,
2005; Martinez et al., 2007). More research is, however,
required to determine what are the potentially significant
implications of such proton sensitivity for the immune func-
tions mediated by P2X7 receptors.
In summary, this study shows that acidic pH modulated rat
P2X7 receptor by inhibiting the maximal responses without
altering agonist sensitivity and the inhibition involved His85,
Lys110, Lys137, Asp197 and His219 residues in the extracellular
domain of the receptor. The Asp197 residue appeared to be the
most critical residue for such inhibition.
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ABSTRACT
Pannexin (Panx) 1 is a widely expressed protein that shares
structural, but not amino acid, homology with gap junction
proteins, the connexins. Panx1 does not form gap junctions in
mammalian cells, but it may function as a plasma membrane
hemichannel. Little is known of the pharmacological properties
of panx1 expression in mammalian cells. Here, we identify three
variants in the human PANX1 gene. We expressed these vari-
ants and mouse Panx1 in mammalian cells and compared
Panx1-induced currents. All human Panx1 variants and the
mouse Panx1 showed identical protein expression levels, lo-
calization patterns, and functional properties, although the fre-
quency of functional expression was species-dependent.
Panx1 currents were independent of changes in extracellular or
intracellular calcium or phospholipase C transduction. We
found compounds that inhibited Panx1 currents with a rank
order of potency: carbenoxolone ! disodium 4,4"-diisothio-
cyanatostilbene-2,2"-disulfonate (DIDS) # disodium 4-acet-
amido-4"-isothiocyanato-stilben-2,2"-disulfonate # 5-nitro-2-
(3-phenylpropylamino)benzoic acid ! indanyloxyacetic acid 94
!! probenecid !! flufenamic acid $ niflumic acid. Triphos-
phate nucleotides (ATP, GTP, and UTP) rapidly and reversibly
inhibited Panx1 currents via mechanism(s) independent of pu-
rine receptors. When Panx1 was coexpressed with purinergic
P2X7 receptor (P2X7R), DIDS was found to act as a P2X7R
antagonist to inhibit ATP-evoked currents, but none of the other
compounds inhibited P2X7R currents. This is the first detailed
pharmacological characterization of Panx1-mediated currents
in mammalian cells and sheds new, although contradictory,
light on the hypothesis that Panx1 acts as a hemichannel to
allow passage of large molecules in response to P2X7R
activation.
Pannexins are a three-membered family of membrane pro-
teins (Panx1–3) that bear topological similarity, but minimal
amino acid homology, to the large family of gap junction
channels, the connexins (Panchin, 2005; Barbe et al., 2006).
Unlike connexins, pannexins do not form gap junctions when
expressed in mammalian cells (Huang et al., 2007a) but do
lead to the appearance of ionic currents whose properties
resemble “undocked” gap junction hemichannels (Scemes et
al., 2007). Panx1 has distinct but generally ubiquitous ex-
pression in excitable and nonexcitable cells and has gener-
ated increasing interest as a likely hemichannel conduit for
nonvesicular release of ATP from erythrocytes and taste re-
ceptor cells (Locovei et al., 2006a; Huang et al., 2007b).
Panx1 has also been shown to form protein-protein associa-
tion with the purinergic P2X7 receptor (P2X7R), whose acti-
vation by extracellular ATP opens a typical cationic channel
within milliseconds followed seconds later by an opening, or
activation, of a large pore permeable to molecules up to 900
Da (Pelegrin and Surprenant, 2006). The initial phase of this
P2X7R-activated dye-permeable pore is inhibited by blockade
of Panx1 using siRNA knockdown techniques, by a Panx1-
mimetic inhibitory peptide, and by the relatively nonselective
gap junction channel blocker, carbenoxolone (CBX) (Pelegrin
and Surprenant, 2006, 2007). These results have provided
the evidence for the hypothesis that Panx1 hemichannels
open in response to conformational changes of the P2X7R
protein complex upon its activation, thus allowing passage of
the larger molecules through its open hemichannel (Pelegrin
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and Surprenant, 2006; Scemes et al., 2007). Mechanical and
osmotic stimuli and changes in intracellular calcium have
also been suggested to open Panx1 hemichannels in the ab-
sence of P2X7R presence or activation (Locovei et al., 2006b;
Vanden Abeele et al., 2006).
Because the molecular identification of pannexins has oc-
curred relatively recently (Bruzzone et al., 2003; Baranova et
al., 2004), there have been few pharmacological characteriza-
tions of ectopically expressed Panx1 currents, and all have
been carried out using the oocyte expression system (Bruz-
zone et al., 2005; Locovei et al., 2006b; Silverman et al.,
2008), with the exception of our previous study of human
Panx1 currents expressed in HEK293 cells (Pelegrin and
Surprenant, 2006). Expression of Panx1 in either oocytes or
mammalian cells results in ionic currents that are in general
agreement; that is, currents activate upon depolarizations
greater than !10 mV, show minimal time dependence of
activation, are rapidly and reversibly inhibited by CBX at
concentrations (EC50 ! 5 "M) that are 5- to 20-fold less than
required to inhibit connexin-mediated currents, are indepen-
dent of external calcium, and are only weakly inhibited by
flufenamic acid, a commonly used inhibitor of both chloride
channels and gap junction channels (Bruzzone et al., 2005).
Few other pharmacological properties of Panx1-mediated
currents are known, although probenecid, a compound long
used clinically for the treatment of gout and thought to act by
inhibiting specific plasma membrane anionic transporters,
has been shown recently to block Panx1 currents in oocytes
without inhibiting connexin (46 and 32) currents (Silverman
et al., 2008). In contrast, there seem to be striking discrep-
ancies in results obtained from oocyte expression and mam-
malian cell expression when P2X7R is coexpressed with
Panx1. In the oocyte expression system, currents in response
to ATP activation of ectopically expressed P2X7R is inhibited
by CBX and mefloquine (Iglesias et al., 2008), but in mam-
malian expression systems, no inhibition of P2X7R-mediated
currents by these compounds is observed (Pelegrin and Sur-
prenant, 2006).
The present study was undertaken to expand the currently
limited repertoire of compounds that may act on Panx1,
particularly in mammalian cell expression systems. We car-
ried out quantitative comparisons of currents induced by
expression of human and mouse Panx1 in HEK293 cells (in
the absence of P2X7R). We found that ATP and other nucle-
otides directly inhibited both human and mouse Panx1 cur-
rents in a purine receptor-independent manner, that Panx1
currents were independent of intracellular calcium concentra-
tions, and that some nonselective chloride channel inhibitors
(NPPB, DIDS, IAA-94) blocked Panx1 currents, whereas others
(FFA, NFA, 9-AC, MFQ, DPC) had little or no effect. DIDS, but
none of the other compounds, inhibited P2X7R-mediated cur-
rents in cells expressing only P2X7R or in cells coexpressing
both P2X7R and Panx1. These results expand the previously
limited pharmacological profile of panx1 currents and show
that inhibition of panx1 currents is independent of inhibition of
P2X7 receptor currents.
Materials and Methods
Materials. All salts and compounds used in this study were from
Sigma Chemical (Poole, Dorset, UK), with the exception of DPC
from Merck Chemicals (Nottingham, UK) and U73122 and U73343
from Calbiochem (San Diego, CA). Panx1 antibodies were from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA), Millipore Corporation
(Billerica, MA), or DIATHEVA s.r.l. (Fano, Italy) or generously sup-
plied by S. Scherer (University of Pennsylvania, Philadelphia, PA).
Secondary Abs were from Dako UK Ltd. (Ely, Cambridgeshire, UK),
and all cell culture media, Optimem, and Lipofectamine 2000 were
from Invitrogen (Paisley, UK).
Cells, Transfections, Cloning, and siRNA. HEK293 cells were
originally obtained from the American Type Culture Collection (Ma-
nassas, VA) and maintained as described previously (Pelegrin and
Surprenant, 2006). Transient transfection was carried out similarly
for all cell lines using Lipofectamine 2000 (Invitrogen, Carlsbad,
CA), as described in detail previously (Roger et al., 2008). Unless
otherwise stated, Panx1 cDNA (1 "g) was cotransfected with eGFP
(0.1 "g), and electrophysiological recordings were made 24 to 48 h
post-transfection. siRNA for human Panx1 has been described pre-
viously (Pelegrin and Surprenant, 2006). Human Panx1 expression
vectors have been described previously (Pelegrin and Surprenant,
2006); the full-length sequence encoding mouse Panx1 was amplified
from total mouse C57 BL/6 brain mRNA using reverse transcriptase-
PCR and cloned into pcDNA3.1(#) vector (Invitrogen). c-myc
(EQKLISEEDL) and eGFP tags were introduced in-frame at the 3$
end of the coding sequence of mouse Panx1 using overlapping PCR
and Accuzyme proof-reading DNA polymerase (Bioline); DsRed tag
was introduced in-frame at the 3$ end of the coding sequence of
human Panx1; FLAG tag (DYKDDDDK) was introduced in the sec-
ond extracellular loop of human Panx1-myc at position 162 to 168,
hence incorporating a c-myc, eGFP, or DsRed fusion tag at the C
terminus or a FLAG tag at the second extracellular loop of the
expressed protein. The different human Panx1 splice variants and
the deletion of V377 were generated from the hPanx1-ee construct
using the PCR overlap extension method (Young et al., 2007) and
Accuzyme DNA polymerase. Cloned products were confirmed by
sequencing (Beckman Coulter CEQ 2000 Dye Terminator; Beckman
Coulter, Fullerton, CA), and protein expression was verified byWest-
ern blotting.
Immunohistochemistry. For immunohistochemistry, cells were
transfected as described above on coverslips or in 35-mm Petri dishes
and plated onto coverslips 4 h post-transfection; cells were examined
24 to 48 h later. Cells were washed twice with PBS followed by
fixation [4% (v/v) formaldehyde in PBS] for 30 min at room temper-
ature, then permeabilized with blocking solution (0.1% Triton X-100
and 0.3% bovine serum albumin in PBS) for 40 min. Cells were then
incubated with primary Ab against Myc-tag (1:1000 in the blocking
solution) for 1 h at room temperature. After washing three times
with PBS, anti-mouse IgG Alexa Fluor 594 conjugated secondary Ab
(1:200; Invitrogen) was applied for 30 min. 4,6-Diamidino-2-phe-
nylindole (Invitrogen) was used for nuclear staining. After brief rinse
in H2O, coverslips were mounted on slides with Gold antifade re-
agent (Invitrogen). Cells were photographed using Zeiss Plan-
Neofluar 100% oil and AxioVision software (Zeiss, Welwyn Garden
City, UK), Nikon Eclipse TE300 confocal 60% objective and EZ-C1
software (Nikon, Tokyo, Japan), or Olympus IX71 100% objective
with SoftWoRx 3.5 [DeltaVision; Image Solutions (UK) Ltd, Preston,
UK], as indicated. We generated several epitope-tagged Panx1 pro-
teins; there were no differences between human and mouse Panx1
protein localization when expressed in HEK293 cells (Supplemental
Fig. 1). C-terminal fusion of large epitopes (eGFP or DsRed) resulted
in Panx1 protein remaining intracellular in vacuole-like compart-
ments, whereas smaller epitopes (c-myc or ee-tags) showed intense,
plasma membrane-delimited expression (Supplemental Fig. 1, A
and B).
Reverse Transcription and PCR Analysis. Human brain RNA
(Ambion, Austin, TX) and total RNA from other cells were isolated
using the RNeasy Mini kit (QIAGEN, Valencia, CA), followed by
reverse transcription using SUPERSCRIPT III (Invitrogen) RNase
H-reverse transcriptase with oligo(dT). Genomic DNA was isolated
by digesting 106 cells in a buffer containing 23 mg/ml proteinase K
410 Ma et al.
and 0.5% Triton X-100 at 56°C for 60 min. Panx1 was amplified by
standard PCR protocols from cDNA using specific oligonucleotides
that differentiate between the alternative splice variant on exon 5
(F1/Ra or F1/Rb; Supplemental Table 1) or the deletion of a single
Val at position 377 in exon 4 (F1/Rvv or F1/Rv; Supplemental Table
1); oligonucleotides annealing at both sides of intron 4 (F4/R2, Table
1) were used to amplify human Panx1 from genomic PCR, and this
fragment contains V377 position in the exon 4; !-actin primers have
been reported previously (Pelegrin and Surprenant, 2006). The PCR
conditions to distinguish between the different Panx1 variants were
20 cycles with a stringent annealing temperature of 65°C for the a/b
splicing variant and 70°C for the V377 deletion. The obtained prod-
uct sizes for all PCR products were as expected from their mRNA
sequence or from the genomic DNA and were for F1/Ra, 675 bp
(Panx1a); for F1/Rb, 690 bp (Panx1b) or 687 bp (Panx1bv); for F1/
Rvv, 610 bp (Panx1b); for F1/Rv, 607 bp (Panx1bv); for F4/Rvv, 445
bp (Panx1b); for F4/Rv, 442 bp (Panx1bv); for F4/R2, 1110 (Panx1b),
1098 (Panx1a), and 1107 (Panx1bv) bp; and 1129 bp for !-actin.
Electrophysiology. Whole-cell patch-clamp recordings were
made at room temperature using an EPC9 amplifier, Pulse acquisi-
tion software (HEKA, Lambrecht/Pfalz, Germany), and AxographX
analysis software (AxoGraph Scientific, Sydney, Australia) as de-
tailed recently (Roger et al., 2008). Membrane potential was held at
"60 mV unless otherwise indicated. Compounds were applied by the
RSC fast flow system (Biologique, Grenoble, France); drug equilibra-
tion time ranged from 20 ms to 1 s, depending on the distance of the
fast-flow tube from the recorded cell. We also superfused compounds
for 3 to 6 min in addition to fast-flow application for those compounds
that showed little or no effect to ensure complete drug access and
equilibration. Recordings were made only from single cells to rule out
possible contributions because of electrical coupling between cells,
and in the majority of recordings, the cell was lifted up from the
coverslip after obtaining whole-cell configuration to further ensure
complete drug delivery and confirm absence of coupled cells. Cells
were chosen of approximately similar size and shape throughout this
study; in accordance, whole-cell membrane capacitance showed min-
imal variability (range, 8–12 pF; mean # S.E.M., 9.6 # 0.2 pF);
therefore, all results are shown as absolute current values. Standard
intracellular/extracellular solutions were: 147 mM NaCl, 10 mM
HEPES, 10 mM EGTA/147 NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM
CaCl2, 10 mM HEPES, and 13 mM glucose; intracellular calcium
concentrations were calculated using WebMaxC software (http://
www.stanford.edu/$cpatton/webmaxcS.html). All solutions were at
pH 7.3 and 300 to 315 mOs/mol. In most experiments, voltage ramps
("120 to 80 mV) were applied at 2- to 10-s intervals after steady-
state dialysis of internal solutions had been attained, usually within
2 to 3 min after obtaining whole-cell conditions. Voltage steps
(20-mV increments at 1-s intervals from "120 to 80 mV) were also
applied before, during, and after application of compounds. Concen-
tration-response inhibition curves were determined by least-squares
fit to the Hill equation: I/Imax % 1/[1 & (B/IC50)nH], where I is the
current as a fraction of control (Imax at 70 mV), and B is the concentra-
tion of inhibitor. Figures show curves fitted to the mean of all experi-
ments; Kaleidagraph software (Abelbeck/Synergy, Reading, PA) was
used for curve fitting and statistical analysis via Student’s t test.
Fura-2 Calcium Assay. Cells were plated in a 96-well black
assay plate with clear bottom (Corning Inc., Corning, NY) and cul-
tured overnight to reach 90 to approximately 100% confluence. Cells
were preincubated with 4 'M Fura-2 AM (Invitrogen) at 37°C for 30
min. Before recording, Fura-2 AM was removed and replaced with
the standard extracellular solution. Fluorescence was recorded by an
automatic fluorescence plate reader, FlexStation 3 (Molecular De-
vices, Sunnyvale, CA) over 5 to 10 min at 4-s intervals. The dual
excitation for Fura-2 was 340 nm/380 nm, and the emission was 510
nm. Agonists were added into the wells automatically by the ma-
chine at designated time points, whereas any antagonists were
added to the wells 5 min before recording started. Data were ac-
quired by the SoftMax Pro 5 software, and the intracellular calcium
level was expressed as the ratio of the emission intensities for 340
and 380 nm.
Results
Splice Variants and Single-Nucleotide Polymor-
phism in Human Panx1. It has been reported that human
Panx1 presents an alternatively spliced exon 5 leading to
the synthesis of Panx1 with two intracellular C terminus
lengths: Panx1a and Panx1b, containing a four-amino acid
insert (GMNI) at position 400 (Fig. 1A) (Baranova et al.,
2004). We examined the expression of these two variants in
different human cell lines (HEK293, HeLa, and THP-1) and
in total human brain by using oligonucleotides to specifically
amplify by PCR both splicing variants (Supplemental Table
1) and confirmed the selectivity of both oligonucleotide pairs
by amplifying an expression vector carrying either human
Panx1a or Panx1b coding sequence (Fig. 1B). It is surprising
that there was no expression of Panx1a in any cell line or
tissue examined (Fig. 1B), although Panx1b was strongly
expressed in all preparations (Fig. 1C). Both variants simi-
larly trafficked to the plasma membrane when tagged with
c-myc or ee-epitopes as revealed by immunocytochemistry in
HEK293 cells expressing either Panx1a or b (Fig. 1D). We
initially cloned human Panx1 from the THP-1 macrophage
cell line (Pelegrin and Surprenant, 2006) and noted that
some clones contained a Panx1 coding sequence carrying a
deletion of a single valine in the intracellular C terminus
domain at position 377 (Panx1bv; Fig. 1A). By using specific
oligonucleotides (Supplemental Fig. 2), we were able to dif-
ferentially amplify both Panx1 variants from cDNA or
genomic DNA. We found that HEK293 and THP-1 cells ex-
press both versions V377/V378 (Panx1b) and single V377
(Panx1bv) mRNAs, whereas HeLa cells or human brain ex-
press only Panx1b mRNA (Fig. 1B). Genomic differential
amplification for V377 deletion revealed that THP-1 cells
carry both versions in their genome, and, as expected, HeLa
cells only presented with the Panx1b version (Fig. 1C). Lo-
calization of human Panx1bv was found in the plasma mem-
TABLE 1
IC50 values (micromolar) for inhibition of Panx1 currents and
comparison with actions of these compounds at P2X7R
Numbers in parentheses are n values.
IC50 Values
Mouse Panx1 Human Panx1 Effect on P2X7R Current
'M
CBX 4 # 0.6 (29) 2 # 1 (18) 5–10% Increase (14)
DIDS 9 # 2 (6) 11 # 2 (4) Receptor antagonist*
NPPB 15 # 2 (12) 21 # 4 (4) 15% Increase (6)
SITS 11 # 3 (6) 13 # 3 (4) Not examined
IAA-94 95 # 6 (5) Not examined Not examined
FFA (1000 (6) (1000 (8) No effect (5)
NFA (1000 (5) (1000 (4) No effect (5)
Probenecid 352 # 31 (5) 360 # 21 (3) No effect (3)
MFQ No effect** (12) No effect** (5) No effect* (12)
ATP 752 # 42 (8) 825 # 56 (12) Receptor agonist***
UTP 1256 # 56 (7) 1350 # 60 (4) No effect (4)
GTP 1290 # 87 (6) 1420 # 108 (3) No effect (4)
* IC50 for DIDS at rat, mouse, and human P2X7R % 90, 130, and 195 'M,
respectively (see Fig. 8).
** Concentrations from 1 nM to 10 'M.
*** EC50 for activation at rat, mouse, and human P2X7R % 640 # 22, 985 # 35,
and 952 # 120 'M, respectively. Numbers of cells tested are indicated in
parentheses.
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brane, similar to Panx1b (Fig. 1D), indicating no major traf-
ficking defects in Panx1 by the deletion of V377.
Functional Expression of Human and Mouse Panx1.
Transient transfection of mPanx1 (untagged, ee, or c-myc
tagged) in HEK293 cells resulted in the appearance of a
distinct current whose properties were virtually identical to
those described previously for heterologous expression of
hPanx1 in HEK293 cells (Pelegrin and Surprenant, 2006).
The Panx1-associated current, activated at membrane poten-
tials !10 mV, showed no desensitization during maintained
depolarizations for up to 1 min and was rapidly (within 10
ms) and reversibly (within 1 s) blocked by CBX (30 or 50 "M)
(Fig. 2A). In approximately 50% Panx1 or vector-transfected
cells and 20% of untransfected cells, a lanthanum-sensitive
inward current was apparent (Fig. 2A). In the absence of
lanthanum, this current was increased by up to 10-fold by
CBX (data not shown); therefore, we used lanthanum (2 mM)
in all solutions when this Panx1-independent current was
observed. Lanthanum neither had any effect on the CBX-
inhibited outward current recorded in Panx1-transfected
cells (Fig. 2A), nor did it alter the actions of any of the
compounds we examined in the present study. Therefore, we
defined the difference between the current in the presence of
2 mM lanthanum and the current in the presence of 2 mM
lanthanum plus 50 "# CBX as the Panx1 current. Although
both human and mouse Panx1 protein showed intense
plasma membrane localization in !95% of all transfected
cells (e.g., Supplemental Fig. 1), the frequency of recording
hPanx1-associated currents was very low (8–35% cells), com-
pared with mPanx1-transfected cells (80–85% cells; Fig. 2D).
No hPanx1-mediated currents were recorded from hPanx1-
eGFP transfections, and only two of 30 mPanx1-GFP cells
exhibited currents (Fig. 2D), thus confirming the minimal
to absent functional expression of these epitope-tagged pro-
teins. However, when all other data were considered (i.e.,
excluding GFP and DsRed-tagged cDNA), there were no sig-
nificant differences in average or maximal current ampli-
tudes of Panx1-associated currents in cells transfected with
any of the human or mouse Panx1 constructs (Fig. 2E).
Panx1 Currents Are Calcium-Independent. Chang-
ing extracellular calcium concentration from control (2
mM) to 10 mM or to calcium-free/1 mM EGTA solution did
not alter hPanx1 or mPanx1 currents (n $ 9–15 for each;
Fig. 3A). We also did not observe any differences in aver-
age or maximal current amplitudes of Panx1 currents from
cells dialyzed with low intracellular calcium (calculated
%1 nM) or with high intracellular calcium (calculated 720
nM; Fig. 3A). However, it has been reported that activation
of PLC-coupled metabotropic P2Y receptors leads to acti-
vation of human Panx1 when expressed in oocytes (Locovei
et al., 2006b). Therefore, we examined in more detail pos-
sible modulation of Panx1 currents by altered intracellular
calcium concentrations by using the PLC inhibitor U73122.
Application of U73122 to untransfected, vector-transfected,
or Panx1-transfected HEK293 cells resulted in a time-depen-
dent increase in inward and outward currents; lanthanum (2
Fig. 1. Characterization of human
Panx1 variants. A, multiple align-
ment of the different human Panx1
variants (Panx1a AAK91713, Panx1b
NP_056183, Panx1bv FM201789) with
mouse Panx1 (NP_062355) correspond-
ing to the residues 372 to 407 of the
intracellular C terminus in human
Panx1a. B, expression profile of Panx1
variants by reverse transcriptase-PCR
in different human cell lines and in the
brain. Note the lack of Panx1a expres-
sion. C, detection of Panx1b and
Panx1bv by PCR in the genomic DNA
of HeLa and THP-1 cells. Expression
vectors for the different Panx1 variants
were used as a positive control to con-
firm the specific amplification by the
different oligonucleotide combinations
(B and C). D, cellular localization of the
different Panx1-ee-tagged variants ex-
pressed in HEK293 by confocal micros-
copy. Note similar membrane localiza-
tion for all variants.
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mM) completely blocked these U73122-induced currents (Fig.
3B) and, therefore, were not attributed to panx1 activation.
After blockade of the Trp-like currents with lanthanum (Fig.
3C), U73122 now produced a time-dependent inhibition of
the Panx1-associated current; the maximal inhibition by
U73122 (10 !M) was 80% of the inhibition produced by CBX
(Fig. 3D). The time constant of inhibition was 1.3 min (Fig. 4).
Neither the kinetics of U73122 inhibition nor the maximal
inhibition were altered by dialyzing cells with low ("1 nM) or
high (720 nM) intracellular calcium. Likewise, no changes
occurred when external calcium was removed in addition to
treating cells with BAPTA-AM (Fig. 4A). Moreover, U73343
(10 !M), an inactive analog of U73122 in terms of PLC
inhibition, was equally effective to inhibit Panx1 currents,
although with slower kinetics (time constant of inhibition,
2.5 min; Fig. 4B). We confirmed the selective effectiveness of
U73122 in blocking P2Y-mediated calcium transients from
untransfected, vector-transfected, and Panx1-transfected
HEK cells and found that a 5-min exposure to a 10 !M
concentration of U73122 blocked 95 to 100% of the ATP-
evoked calcium responses, whereas the same concentra-
tion of the PLC-inactive analog, U73343, had no effect
(Supplemental Fig. 3).
Inhibition of Panx1 Currents by Nonselective Chlo-
ride Channel/Anion Transporter Blockers. We exam-
ined a number of compounds that are known to inhibit gap
junctions, cation and anion transporters, Trp channels, and
chloride channels, all of which are relatively nonselective but
may provide a “Panx1-specific repertoire.” Examples of two
compounds, NPPB and SITS, which were effective inhibitors
of mouse and human Panx1 currents, are shown in Fig. 5A,
concentration-inhibition curves for compounds that inhibited
Panx1 currents are shown in Fig. 5B, and inhibitor potencies
are shown in Fig. 5C and Table 1. The most potent inhibitor
was CBX (IC50, 5 !M) and the weakest probenecid (IC50, 350
!M). Lanthanum (2 mM; Figs. 2 and 3), gadolinium (300
!M), 2-APB, 9-AC, and DPC (all at 100 !M) were without
effect (data not shown, n # 4–6) .
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Fig. 2. Functional expression of mouse and
human Panx1. A, currents in response to
voltage steps from $120 to 80 mV and volt-
age ramps from$120 to 80 mV recorded from
HEK293 cells expressing mPanx1. Lantha-
num (2 mM) blocks the inward but not the
outward current, whereas CBX (30 !M)
blocks only the outward current. We have
defined the Panx1 current as the CBX-sensi-
tive component. B, CBX inhibition of human
Panx1 currents; C, rapid onset of CBX inhi-
bition. D, frequency of expression of Panx1
currents from cells transfected with the indi-
cated constructs; in all transfections, equiva-
lent percentage of cells (% 80%) expressed
Panx1 protein as determined by immunohis-
tochemistry (as per Supplemental Fig. 1). E,
mean current at 70 mV recorded from cells
expressing Panx1 currents; there were no sig-
nificant differences among the human vari-
ants or between mouse and human Panx1
currents.
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Inhibition of Panx1 Currents by Nucleoside Triphos-
phates. We examined the actions of ATP on Panx1 currents
with the hypothesis that it was likely to directly activate
Panx1 currents. To our surprise, ATP, UTP, and GTP, but
not ADP, AMP, adenosine, pyrophosphates, or monophos-
phates, rapidly and reversibly inhibited Panx1 currents with
kinetics similar to CBX (Fig. 6). Maximal inhibition by ATP
was 90% CBX inhibition, whereas maximal inhibition by
GTP or UTP was 70% CBX inhibition (Fig. 6, C and E).
BzATP at 300 !M and 1 mM inhibited panx1 currents by
14 " 4 and 36 " 6% (n # 3), respectively; these concentra-
tions of ATP$S inhibited panx1 currents by 24 " 5 and 46 "
6% (n # 3), and %&-meATP (0.5 mM) also inhibited panx1
currents by 34 " 3% (n # 3). It was not economically feasible
to examine higher concentrations of these analogs. There
were no significant differences in ATP concentration-inhibi-
tion curve or kinetics of ATP inhibition when high concen-
trations of ATP were included in the recording pipette (10–20
mM, n # 17 for mPanx1 and 14 for hPanx1; Fig. 6D); intra-
cellular ATP also did not alter the average or maximal Panx1
currents. The simultaneous inclusion of nonselective purine
receptor antagonists, suramin (200 !M) and pyridoxal phos-
phate-6-azophenyl-2',4'-disulfonic acid (100 !M), did not al-
ter the inhibition by ATP, GTP, or UTP (n # 2 for each
nucleotide).
Actions of Panx1 Inhibitors on P2X7R-Mediated Cur-
rents.We examined the actions of compounds that inhibited
Panx1-currents on ATP-evoked currents in cells coexpressing
rat P2X7R ( mPanx1, human P2X7R ( mPanx1, mouse
P2X7R ( mPanx1, and rat P2X7R ( hPanx1. In all these
cells, a CBX-sensitive Panx1 current was recorded in the
absence of ATP (data not shown). ATP evoked typical P2X7R-
mediated currents (Fig. 7A). CBX, NPPB, FFA, MFQ, NFA,
and probenecid had no effect or increased by 10 to 20% the
peak current in response to ATP (Fig. 7A; Table 1). In con-
trast, DIDS readily inhibited P2X7R-mediated currents (Fig.
7, B and C) with IC50 values that were 10- to 20-fold higher
than IC50 values for inhibition of Panx1 currents (Fig. 7C;
Table 1).
Discussion
This study provides the first detailed pharmacological
characterization of Panx1-associated currents in mammalian
cells and presents results that may call for revision of current
hypotheses regarding Panx1 function.
Protein and Functional Expression of Panx1 Vari-
ants.Human Panx1 presents an alternatively spliced exon 5,
which leads to a four-amino acid insert (GMNI) within the
intracellular C terminus (Panx1b; Fig. 1A). This splicing
variant was initially characterized by expressed sequences
tag database searches (Baranova et al., 2004); however, no
protein or functional expression studies of this Panx1b vari-
ant have been carried out previously. In the present study,
we examined several different human cell lines and brain
tissue and found that Panx1b is the only Panx1 present.
Fig. 3. Panx1 currents are not modulated by calcium. A,
mPanx1 currents recorded with low internal calcium ()1 nM),
high internal calcium (720 nM) with 2 mM external calcium, or
low internal calcium and zero external calcium. B, activation of
Trp-like currents in response to U73122 (10 !M, blue traces
recorded at 1-min intervals). C, currents in absence (black trace)
or presence of 2 mM lanthanum (blue traces at 1-min intervals),
which show no change in CBX-sensitive Panx1 current over this
time course. D, currents in U73122( lanthanum (blue traces at
1-min intervals); Panx1 currents are now inhibited. E, PLC-
inactive analog, U73343 (10 !M), also inhibited Panx1 currents.
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Although the initial report by Baranova et al. (2004) sug-
gested the Panx1a splice variant is the more common form,
our study reveals it is the Panx1b variant that should be
considered to be most prominent. We also identified a novel
difference in the intracellular C terminus of human Panx1, a
specific deletion of valine at position 377 (Panx1bv). The
V377 coding sequence is present in exon 4, and the lack of
this amino acid cannot be explained by an alternative spliced
exon. However, the two consecutive valines at positions 377
and 378 present in the human Panx1 sequence (accession
numbers AAK91713 and NP_056183) are encoded by a du-
plication of the same codon GTT at position 1131 in the
coding sequence; therefore, there are four different possibil-
ities for a trinucleotide deletion to occur in that position to
produce a single valine at position 377 (GTT1131, GTT1134,
TTG1132, or TGT1133). Both forms of Panx1, b and bv, were
expressed in HEK293 and THP-1 human cell lines. Coding
sequences for both variants were found in THP-1 genomic
DNA, indicating that these cells carry the V377 deletion only
in one allele of the PANX1 gene. We were unable to detect
expression of Panx1bv from HeLa cells or from the brain, and
further studies will be needed to explore whether Panx1bv is
present in the human population. In any case, all Panx1
variants (Panx1a, Panx1b, and Panx1bv) were found to be
equally trafficked to the plasma membrane (unless fused
with GFP or DsRed), and they all showed the same electro-
physiological profile, indicating that their functional proper-
ties remain the same irrespective of the Panx1 splice variant
expressed in a specific tissue or the presence of Panx1bv in
the genome.
Inhibition of Panx1 Currents by Chloride Channel/
Transporter/Gap Junction Channel Blockers. We iden-
tified a number of compounds that reversibly inhibited
Panx1 currents (Table 1); all are known to inhibit rather
nonselectively gap junction channels, chloride channels,
and/or anion transporters. The rank order of potency for
inhibition of either human or mouse Panx1 currents was
CBX ! DIDS " SITS " NPPB ! IAA-94 !! probenecid !!
FFA # NFA. However, not all gap junction/chloride channel
blockers were effective because heptanol, 9-AC, MFQ, and
DPC did not alter human or mouse Panx1 currents, nor did
the nonselective Trp-channel/voltage-gated calcium channel
blockers, lanthanum and gadolinium. Therefore, the profile
presented by the above repertoire of inhibitors provides a
useful pharmacological fingerprint to identify and distin-
guish native Panx1 currents. Although we have not exam-
ined directly mechanisms of inhibition by any of these com-
pounds, the millisecond on and off rates of inhibition by CBX,
NPPB, and DIDS suggest direct channel block. Probenecid,
recently shown to block Panx1-induced but not connexin-
mediated currents when expressed in oocytes (Silverman et
al., 2008), showed much slower kinetics with on and off rates
Fig. 4. Kinetics of calcium-independent inhibition of Panx1 currents by
U73122 and U73343. Summary of all experiments as illustrated in Fig. 3.
A, inhibition by U73122 as a function of time in different internal/
external calcium concentrations; there were no significant differences. B,
kinetics of inhibition by U73122 and U73343; inhibition by U73343 was
slower than U73122, but the same maximal inhibition occurred with
either compound.
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in the minute domain, suggesting a distinct mechanism of
inhibition. Because probenecid had been considered previ-
ously to act solely through anion transporter inhibition, Sil-
verman et al. (2008) have raised the possibility that Panx1
may function as an essential component in a transport pro-
tein complex rather than as a separate permeation pathway.
Our results add weight to this possibility because all the
compounds (except CBX) we found to inhibit Panx1 currents
are also known to inhibit various anion transporters and
other members of the ATP-binding cassette family of trans-
porters (Gelband et al., 1996; Strange et al., 1996; Kidd and
Thorn, 2000). It is not known whether CBX alters trans-
porter functions because no studies examining actions of
CBX on anion or other types of transporters have been car-
ried out to date.
Calcium Independence. Panx1 currents were unaltered
by increasing or removing extracellular calcium, by markedly
reducing levels of intracellular calcium (to !1 nM) via dial-
ysis with high concentrations of BAPTA, or by loading cells
with BAPTA-AM, or by greatly increasing intracellular cal-
cium levels via dialysis of "M concentrations of calcium.
Although studies to date on Panx1 function are in agreement
that Panx1 currents are not modulated by extracellular cal-
cium (Bruzzone et al., 2005; Pelegrin and Surprenant, 2006),
it has been reported that Panx1 currents in oocytes can be
activated by increased intracellular calcium, particularly by
activation of the PLC pathway by purinergic P2Y receptors
(Locovei et al., 2006b). In the present study, we further
examined the actions of the PLC inhibitor, U73122, and
found it did inhibit Panx1 currents, but the inhibition was
not via PLC transduction because the PLC-inactive analog,
U73343, was equally effective in blocking Panx1 currents,
and the U73122-induced inhibition of currents did not de-
pend on levels of intracellular calcium. Thus, the inhibition of
Panx1 currents by U73122 and U73343 is independent of
modulation of intracellular calcium and probably reflects direct
modulation of the Panx1 protein or protein complex itself.
Nucleotide Inhibition of Panx1 Currents and In-
volvement of Panx1 in P2X7R Function. In cells express-
ing Panx1 (but lacking P2X7R), trinucleotides all rapidly and
reversibly inhibited Panx1 currents in a manner similar to
that observed for CBX. Although HEK293 cells are well
known to endogenously express several P2Y receptors (but
not P2X receptors), the nucleotide inhibition of Panx1 was
clearly not mediated via activation of any metabotropic P2Y
receptor because inhibitory concentrations of ATP, GTP, and
UTP were 50- to 100-fold greater than required to activate
P2Y receptors because GTP does not activate P2Y (or P2X)
receptors and because the combined application of suramin
and pyridoxal phosphate-6-azophenyl-2#,4#-disulfonic acid
did not alter the inhibitory actions of these trinucleotides.
The rapid kinetics of the nucleotide inhibition, the high con-
centrations required, and the lack of effect of intracellular
ATP are in keeping with direct channel block as the most
likely mechanism of action. There are several examples of
similar blockade of channel activity by ATP, particularly at
chloride channels (e.g., Jackson and Strange, 1995).
ATP rapidly and reversibly inhibited Panx1 currents over
the same concentration range (IC50 $ 750 "M) that activates
P2X7R channels. This result was unexpected because our
previous results had led us to hypothesize that activation of
P2X7R by extracellular ATP induced the opening of Panx1
channels, which allowed passage of higher mol. wt. molecules
(up to 900 Da). The evidence for this hypothesis was that
Panx1 and P2X7R showed protein-protein interaction and
that CBX, siRNA directed against Panx1, and a Panx1-mi-
metic peptide all inhibited the early dye uptake associated
with P2X7R activation without altering P2X7R currents or
calcium flux (Pelegrin and Surprenant, 2006). In the present
study, we again found that CBX produced a small increase in
peak ATP-evoked currents in cells cotransfected with any
combination of mouse, rat, and human P2X7R with mouse or
human Panx1, although the Panx1 currents recorded (in the
absence of ATP) in the same cells showed the same CBX-
induced inhibition as was observed in cells expressing only
Panx1. Similar small increases in ATP-evoked currents oc-
curred in the presence of NPPB, FFA, and probenecid, al-
though DIDS inhibited P2X7R-mediated currents in a con-
centration-dependent manner, thus demonstrating that
DIDS is an effective P2X7R antagonist. Irrespective of the
small increase in ATP-gated currents in P2X7R-expressing
cells by panx1 blockers, these results show clearly that, with
the exception of DIDS, blockers of panx1 currents do not
inhibit P2X7R. Is it possible to reconcile these results with
the hypothesis that activation of Panx1 hemichannels in
response to P2X7R stimulation provides the conduit for dye
uptake? That is, ATP potently inhibits Panx1 currents in
cells lacking P2X7R at the same concentrations that activate
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recorded with high intracellular ATP (20 mM); no differences in peak
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the P2X7R and its subsequent downstream signaling to dye
uptake. We believe these results are not compatible with
Panx1 acting as a dye-permeable hemichannel, although it is
possible to imagine a situation where two functionally dis-
tinct populations of Panx1 hemichannels exist: one popula-
tion associating within the P2X7R protein complex whose
conformation does not allow direct ATP binding (so it opens
in response to P2X7R activation) but retains inhibitory ac-
tions of CBX/NPPB/probenecid and a second population that
does not associate with P2X7R and is available for direct ATP
inhibition by these panx1 blockers. However, we think it
more likely that there remain one (or more) yet-to-be-identi-
fied molecule(s) that link Panx1 to P2X7R-mediated dye up-
take and other downstream signaling cascades initiated by
P2X7R. We predict at least one of these postulated Panx1-
P2X7R-interacting proteins will be a type of anion trans-
porter. Mutagenesis approaches designed to delineate resi-
dues in the Panx1 protein that are sites of interaction for
ATP and other inhibitory compounds and to determine re-
gions that can be directly associated with ion flux should
provide important information concerning how Panx1 may
(or may not) function as an ion channel. Proteomic ap-
proaches aimed at identifying proteins associated within a
P2X7R-Panx1 cocomplex should provide new candidates that
may clarify how Panx1 is modulated by, or itself modulates,
the P2X7R. Most pertinently, continued pharmacological in-
vestigations aimed at identifying further, and more selective,
agonists and antagonists of Panx1 will be key to furthering
our understanding of Panx1 function.
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Legends for Supplemental Figures 
 
Supplemental Figure 1.  Protein localization and expression of mouse and human 
Panx1 in HEK293 cells.  A, immunohistochemistry showing intense plasma 
membrane-delimited localization of both mouse and human Panx1 (as indicated).  B, 
GFP or DsRed fluorescence in cells expressing Panx1-fused proteins as indicated; 
most of the protein is contained in large intracellular bodies. 
 
Supplemental Figure 2. .  Strategy to differentially amplify human Panx1 
variants by PCR.  Two different reverse oligonucleotides were used to differentially 
amplify variants a/b (A) or v/vv (B) (Supplemental Table 1). As shown in the diagram 
the primers differ in the last 3’ nucleotide that allow the TaqDNA polymerase to start 
copying the template DNA. The alignment was complete when annealing temperature 
was 68
o
C for Ra or Rb (A) or 70
o
C for Rv or Rvv (B). 
 
Supplemental Figure 3. Fura2 fluorescence recorded from untransfected HEK293 
cells.  Endogenous P2Y receptors were activated with ATP (30 µM) resulting in 
typical slowly desensitizing calcium transient; this was abolished in the presence of 
U73122 but unaltered in presence of U73343. Average of 8 wells shown in each case.(
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Supplemental Table 1.  Oligonucleotides used to differentiate the different human 
Panx-1 variants. Underlined nucleotides correspond to the primer differences between 
Ra/Rb or Rv/Rvv used to differentially amplify Panx1 sequence variant  
Primer  Sequence (5’ – 3’)     
F1  GCAAAGTTTGTGGGAGGTATC 
F4  GCCTCTCCTCACTCTCAGACG 
Ra  GCTTTAGTTTCACTGTCTT 
Rb  GCTTTAGTTTCACTGTCTAT 
Rv  GGGAGTTTTGCCAATCAACAT 
Rvv  GGGAGTTTTGCCAATCAACAA 
R2  TCAGCAAGAAGAATCCAGAAG 
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Abstract 
 
 Pannexin 1 (Panx1) shares structural similarity but low sequence homology to 
gap junction forming proteins, connexins. It has been proposed that Panx1 functions as 
a hemichannel in actions such as transfer of large molecules and release of ATP. 
However, no detailed characterisation of the biophysical properties of Panx1 is hitherto 
available. Here, we present evidence that Panx1, when expressed in mammalian cells, 
forms anion-selective channels, with a rank order of permeabilities: NO3 > I > Br > Cl > F 
>> aspartate ! glutamate ! gluconate. Panx1 has a medium sized unitary conductance 
around 68 pS. Perfluorooctanoid sulfate polyacrylamide gel electrophoresis (PAGE) and 
cross-linking assays reveal that Panx1 is mainly present as trimer but not as hexamer as 
expected for a hemichannel.  
 
 
 3 
Introduction 
Pannexin 1 (Panx1) is the most ubiquitous of the three members of the 
pannexin gene family [1,2]. Protein and mRNA have been detected in a range of 
mammalian tissues, including the brain and in the immune cells [2,3,4]. The amino acid 
sequence has low homology with gap junction-forming invertebrate proteins innexins [5]. 
Accordingly, pannexins have been considered to be similar to vertebrate gap junction-
forming channels connexins (Cx), with a hexameric structure [6] and the ability to form 
large transmembrane pores [3,7,8].  
 These two considerations, however, lack direct experimental support. Panx1 
sequences are not actually detectably related to those of connexins [2,5] and, with the 
exception of manually paired oocytes [3], there is little evidence that pannexins form gap 
junctions [9,10]. For example, Panx1 currents are not sensitive to block by extracellular 
divalent cations [3] in contrast to connexin currents. It has been suggested that Panx1 
channels can be regulated by cytosolic Ca2+ [8]; however, this has not been confirmed in 
subsequent experiments [11].  The hypothesis that Panx1 functions as a hemichannel 
was also supported by its blockade by carbenoxolone [12] and by knock-down of 
function using siRNA [4] or a sequence-specific Panx1 mimetic inhibitory peptides [4].  
 Panx1 has also been proposed to serve as a conduit for release of ATP from 
erythrocytes, taste bud cells, airway epithelia and possibly in CA3 hippocampal 
neurones [8,13,14,15]. The Panx1 channel opening is typically triggered by 
depolarisation in over-expression systems [11,12], although channel activation has been 
also detected in response to mechanical stimulation in oocyte expression system and 
possibly in erythrocytes [7,16] (but see [17]), to osmotic stress in airway epithelia cells 
[14], or following N-methyl-D-aspartate receptor activation in hippocampal neurones 
[18].   
 Our previous studies made in Panx1-overexpressing HEK293 cells confirmed 
main electrophysiological properties of Panx1-mediated currents as obtained in oocytes. 
We found that the outwardly rectifying Panx1 currents activate at voltages greater than 
~10 mV, that these currents are more sensitive to CBX when compared to Cx-mediated 
currents, and that Panx1 currents are insensitive to extracellular calcium [11]. In this 
 4 
paper, we present a more detailed characterisation of the biophysical properties of 
Panx1 channel when expressed in human embryonic kidney (HEK) 293 cells. We find 
that Panx1 is permeable to chloride and other anions. Biochemical assays in these cells 
indicate that Panx1 forms mainly as trimer, rather than as the hexamer expected for a 
hemichannel. 
 5 
Results 
 
Membrane localisation of Panx1 in HEK cells 
The sub-cellular localisation of Panx1 expressed in HEK cells was visualised by 
immunocytochemistry using a Myc-tagged construct. After cell-surface biotinylation 
performed on living cells, membrane proteins and mPanx1-Myc were detected using 
streptavidin-Texas Red and Myc-FITC antibody, respectively. The maximum intensity of 
Panx1 staining was at the plasma membrane (Fig. 1A). The membrane localisation of 
mPanx1-Myc was further confirmed by determining the levels of expression from cell-
surface biotinylation (Fig. 1B). After Myc immunoprecipitation, the membrane fraction of 
Panx1 was detected using streptavidin-HRP.  
 Relative membrane expression of Panx1 measured by streptavidin labelling was 
about five-fold higher for K36E and R299E point substitutions. These mutations reverse 
the charge of two amino acids located at the inner (cytoplasmic) ends of the first and 
fourth transmembrane domains (Fig. 1B). Total protein expression was unaffected, as 
judged by immunoprecipitation with the Myc antibody (Fig. 1B). Panx1 currents, defined 
by carbenoxolone-sensitive component measured at 70 mV, were also about five times 
larger in these point mutations (K36E: 1300.2 ± 164.4 pA (n = 17), R299E: 1067.8 ± 
218.5 (n = 9), wild type: 207.3 ± 14.4 (n = 87) (Fig. 1C).  
 
Panx1 is predominately a trimer by non-denaturing gel electrophoresis 
 Perfluorooctanoid sulfate polyacrylamide gel electrophoresis (PFO-PAGE) was 
used to separate the proteins according to their native quaternary structure [19]. At high 
PFO concentrations (2 and 4%), two bands were detected with a Myc antibody, 
corresponding in size to a monomer and a dimer (Fig. 2A). In each oligomeric state, two 
glycosylated forms were present, one of which disappeared after incubation of cells with 
tunicamycin (data not shown). At 0.5% PFO, six distinct bands were revealed. 
Measurement of their densities indicated that Panx1-Myc was expressed predominately 
as trimer form (Fig. 2A).  We carried out parallel control experiments with expression of 
P2X2 receptors and connexin 32, which are well known to form trimeric and hexameric  
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Figure 1. Membrane localisation of Panx1 expressed in HEK cells 
 
(A) mPanx1-Myc staining revealed an apparent plasma membrane localisation in 
transfected HEK cells. mPanx1-Myc was stained with a Myc antibody (green) and 
plasma membrane proteins with streptavidin-Texas Red (red) after biotinylation on living 
cells. A densitometry measurement on a section of the cell (indicated by the dashed 
line) demonstrated a high correlation of both signals. (B) However, cell surface 
biotinylation followed by immunoprecipitation with Myc-agarose beads showed a low 
level of plasma membrane expression of the wild type mPanx1-Myc, compared with that 
of mPanx1-K36E-Myc and rP2X2-Myc. The GFP-fused mPanx1 construct abolished 
membrane expression. Plasma membrane protein and total protein were detected by 
streptavidin-HRP and Myc-HRP, respectively. Ratios between the membrane (indicated 
by stretavidin signal) and total (Myc signal) proteins were normalised to mPanx1-Myc. 
(C) A 7-fold increase in the current amplitude (measured at 70 mV) of mPanx1-K36E 
mutant compared with the wild type. *** denotes significance level p < 0.001. 
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membrane proteins [20,21,22]. In our experimental conditions, using 0.5% PFO, these 
proteins were present predominately as trimers and hexamers (Fig. 2A). 
 
Cross-linking indicates a Panx1 trimer 
 Chemical cross-linking agents are commonly used to induce covalent interaction 
between interacting proteins and visualise protein complex on SDS-PAGE gels. We 
used two homo-bifunctional cross-linkers, which are membrane impermeant and react 
with primary amine groups exposed on the cell surface. Using 
bis(sulfosuccinimidyl)suberate (BS3), which has a spacer of 11.4 Å [22], we found that 
Panx1 was mainly present as a monomer after separation on SDS-PAGE. As the 
concentration of this cross-linker and time exposure of the western blot were increased, 
small proportions of dimer and trimer but not products of higher molecular weight were 
observed (Fig. 2B). In the same experimental conditions, P2X7 receptors migrated 
mainly as trimers (data not shown). Using bis(NHS)polyethyleneoxide (PEO5), with a 
spacer of 21.7 Å, the products were also monmeric and dimeric, with a small amount of 
trimer (Fig. 2B).  
 We studied the stochiometry of intracellular Panx1 using two different 
approaches. First, we performed a cross-linking (using BS3 and PEO5) after protein 
solubilisation. In this condition, Panx1 was found to exist as monomer and hexamer (Fig. 
2C), similar to the results of Boassa et al. [23]. However, it is well established that 
protein solubilisation may induce either protein aggregation or interactions that do not 
occur in living cells. We therefore used a membrane permeant cross-linker 
(disuccinimidyl suberate) before protein solubilisation. Fig. 2C shows almost complete 
cross-linking of the dimeric and trimeric forms of Panx1 as the concentration of 
disuccinimidyl suberate was increased. These results suggest that cross-linking of 
solubilised Panx1-Myc induced formation of protein complex that did not occur in living 
cells and that the highest Panx1 complex in living cells was a trimer.  
 We confirmed these results with the heterobifunctional NHS-diazirine (SDA) 
family of cross-linkers. When cross-linked by the non-membrane permeable cross-linker 
sulfo-NHS-succinimidyl-ester diazirine (sulfo-LC-SDA), Panx1 was present mainly in 
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Figure 2. Analysis of native quaternary structure and cross-linking in living cells 
reveals mPanx1 as a trimer 
 
(A) mPanx1 was mainly present as a trimer, as indicated by densitometry measurement 
of the Myc signal from PFO-PAGE. Lysates of HEK cells transfected with mPanx1-Myc 
were incubated with different concentration of PFO before electrophoresis. Under the 
same conditions, the main form of rP2X2-EE and connexin 32-HA was trimer and 
hexamer, respectively. (B) A trimeric oligomeric state of mPanx1, as revealed by cross-
linking in living cells. Homobifunctional and non-membrane permeable cross-linkers, BS3 
and PEO5, were incubated with living mPanx1-Myc transfected HEK cells. (C) 
Comparison of mPanx1 cross-linking on solubilised proteins and on living cells. Cross-
linking of solubilised cell lysates by non-membrane permeable cross-linkers (BS3 and 
PEO5) resulted in a display of hexameric state of mPanx1 while living cells cross-linked 
by membrane permeable cross-linker (DSS) showed a trimeric oligomeric state. (D) 
Cross-linking of mPanx1-Myc by heterobifunctional cross-linkers on living cells. Sulfo-
SDA and SDA are membrane impermeable and permeable, respectively. 
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monomers: a small proportion of trimers could be observed after longer exposure of the 
blot. The trimeric and dimeric forms of Panx1 became predominant when living cells 
were incubated with high concentrations of the membrane-permeable analogue (LC-
SDA) (Fig. 2D). In control experiments, P2X2 receptors migrated as trimers with either 
of these cross-linking agents (data not shown). 
 
Panx1 forms an anion-permeable channel 
 Expression of Panx1 in HEK293 cells resulted in the appearance of a large (n = 
56). This current was reversibly blocked by carbenoxolone (CBX) (10 to 100 "M) and 
this CBX-sensitive component was defined as the Panx1 current (Fig. 3A). When all the 
sodium in the extracellular solution was replaced by N-methyl-D-glucamine (NMDG), the 
reversal potential of Panx1-mediated current was unchanged (n = 10, Fig. 3B). In control 
studies, we measured the reversal potential of currents elicited by ATP (100 "M) in cells 
expressing rat P2X2 receptors: in this case replacement of extracellular sodium by 
NMDG shifted the reversal potential of the current from 0 mV to -81 ± 2.6 mV (n = 6, Fig. 
3B). 
 Replacement of extracellular chloride with aspartate, glutamate or gluconate 
produced a significant shift of the Panx1 current reversal potential (by 39.4 ± 2.2 mV (n 
= 5), 33.5 ± 1.3 mV (n = 6), or 34.7 ± 1.5 mV (n = 6), respectively) (Fig. 3C). These 
substitutions did not change the reversal potential of the ATP-activated current in P2X2 
receptors (n = 6).  When extracellular chloride was partially substituted by aspartate, the 
reversal potential showed an intermediate change (155 mM: -0.2 ± 0.3 mV, n = 20; 57 
mM 15.8 ± 0.7 mV, n = 6; 8 mM: 39.4 ± 2.2 mV, n = 5) (Fig. 4A). Conversely, when 
intracellular chloride was reduced (aspartate substitution) from 147 to 50 and 10 mM, 
the reversal potential shifted from -0.2 ± 0.3 mV (n = 20) to -16.7 ± 0.8 mV (n = 4) and -
39.5 ± 1.0 mV (n = 5), respectively (Fig. 4B). The slope of the line relating the reversal 
potential to the log10 of the chloride concentration was 30.3 mV/log unit (changed 
extracellular) and 33.6 mV/log unit (changed intracellular); this is consistent with the 
relative aspartate permeability (0.16, see below). 
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Figure 3. Panx1 is permeable to chloride but not to sodium 
 
(A) Whole-cell currents of mPanx1 and mock-transfected HEK cells in response to 
voltage steps from -120 to 80 mV with an increment of 20 mV. mPanx1 displayed large 
outwardly rectifying currents, as also seen from voltage ramps protocols (-120 to 70 
mV). The mPanx1 currents were reversibly blocked by CBX (30 "M) or NPPB (100 "M). 
(B) mPanx1 currents reversed at 0 mV when there was no Na or Cl gradient across the 
cell membrane (black traces). Replacement of extracellular Na by NMDG (147 mM 
NMDG outside vs. 147 mM Na inside) did not affect mPanx1 currents (red trace) but 
shifted the reversal potential of the rP2X2 currents to -81 ± 2.6 mV. (C) Substitution of 
extracellular Cl by aspartate right-shifted the reversal potential of the mPanx1 currents 
by 39.4 ± 2.2 mV (red trace) without affecting the rP2X2 currents. 
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Figure 4. Nernstian shift of Panx1 reversal potential by changing transmembrane 
gradients for Cl 
 
(A) When [Cl]o was reduced from 155 mM to 57 mM or 8 mM ([Cl]i was kept at 147 mM), 
the mPanx1 reversal potential shifted from -0.2 ± 0.3 mV to 15.8 ± 0.7 mV or 39.4 ± 2.2 
(red traces), respectively. (B) When [Cl]i was changed from 147 mM to 50 mM or 10 
mM, ([Cl]o remained at 155 mM), the mPanx1 reversal potentials became -16.7 ± 0.8 mV 
or -39.5 ± 1.0 mV. (A, B) The reversal potentials and the respective logarithm of chloride 
concentrations are fitted by a linear relationship with slopes of Erev/log([Cl]o) and 
Erev/log([Cl]i) being -30.3 mV/log unit and 33.6 mV/log unit, respectively. 
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 The relative permeabilities for several monovalent anions were determined by 
measuring the reversal potential when extracellular chloride was substituted with the 
relevant anion (except for fluoride, in which case intracellular chloride was replaced to 
prevent extracellular caclium chelation). The relative permeability ratios were calculated 
using the Goldman-Hodgkin-Katz equation. Table 1 summarises the reversal potentials 
obtained for various anion replacements and their permeability ratios to chloride. The 
rank order of permeabilities was: NO3 > I > Br > Cl > F >> aspartate ! glutamate ! 
gluconate. The average amplitudes of the Panx1 current (measured at 70 mV) recorded 
in NO3, I, Cl and aspartate were 646 ± 99 pA (n = 14), 382 ± 53 pA (n = 9), 207 ± 14 pA 
(n = 87) and 68 ± 6.3 pA (n = 38; Fig. 5A, B).   
 Panx1 currents were reversibly blocked by a range of compounds known to 
block chloride channels. The percentage of maximal inhibition and the IC50 values for 
the compounds tested in this and the previous studies are summarised in Table 2. The 
rank order of potency of these inhibitors is DIDS ! NPPB ! SITS > IAA-94 ! DCPIB > 
glibenclamide (n = 4 - 12 for each). Phloretin, fluoxetine, tamoxifen, diphenylamine-2- 
carboxylate (DPC) and anthracene-9-carboxylic acid (9-AC), however, had no effect on 
Panx1 currents (tested at 100 "M, n = 4 - 6 for each compound, Table 2).  
  
Unitary Panx1 currents 
 Strong depolarization of outside-out patches from cell expressing Panx1 resulted 
in the appearance of discrete unitary outward currents. The unitary currents had an 
amplitude of 5.4 ± 0.6 pA  (n = 4) at 80 mV, providing an estimate of unitary 
conductance of 68 pS. Unitary currents were abolished by NPPB (100 "M) (Fig. 6B). No 
currents were observed at hyperpolarized potentials: however, patches from cells 
transfected with connexin-32 showed clear single channel openings at -80 mV. Their 
amplitude (14.8 ± 0.9 pA, n = 3) at -80 mV provided an estimate of unitary conductance 
of 185 pS (Fig. 6A), similar to the value reported by others [24,25].  
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Table 1.  Relative permeation ratios of monovalent anions to Panx1  
 
 Erev (mV) Px/PCl 
F  -11.2 ± 1.1 (*) 0.69 
Cl -0.2 ± 0.3 1.00 
Br -8.2 ± 0.9 1.33 
I -15.7 ± 1.1 1.81 
NO3 -24.5 ± 2.5 2.58 
Aspartate 39.4 ± 2.2  0.16 
 
* Cl was replaced by other monovalent anions from the extracellular side, except by F 
from the intracellular side.  
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Figure 5. Permeation of Panx1 channel to other monovalent anions  
 
(A) mPanx1 displayed greater permeation to NO3 and I than to Cl but smaller 
permeation to aspartate. (B) When Clo was replaced by the relevant anion, the average 
mPanx1 current amplitudes were 207.3 ± 14.4 pA (in Cl), 646.4 ± 99.1 pA (in NO3), 
382.2 ± 53.1 pA (in I) and 68.5 ± 6.3 pA (in aspartate). The corresponding reversal 
potentials were -0.2 ± 0.3 mV (in Cl), -24.5 ± 2.5 mV (in NO3), -15.7 ± 1.1 mV (in I) and 
39.4 ± 2.2 mV (in aspartate). *** denotes significance level p < 0.001, ** p < 0.01.  
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Table 2.  Inhibition of mouse Panx1 currents by various blockers 
 
Compound IC50 ("M) (n) Maximal inhibition (%) 
CBX 4 ± 0.6 (29) 100 
DIDS 9 ± 2 (6) 100 
NPPB 15 ± 2 (12) 100 
SITS 11 ± 3 (10) 100 
IAA-94 95 ± 6 (10) 95 
DCPIB 12 ± 1 (6) 63 
Glibenclamide 104 ± 2 (6) 62 
Phloretin 49 ± 1 (6) 13 
DPC 30 ± 2 (7) 12 
9-AC n.a. (6) 4 
Fluoxetine n.a. (6) 0 
Tamoxifen n.a. (6) 3 
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Figure 6. Conductance of single Panx1 channel 
 
Outside-out patch-clamp recordings of mPanx1 or Cx32 from HEK cells. Cells were held 
at -60 mV before depolarization/hyperpolarisation. Traces shown are of 1 s duration and 
typical of a continuous recording of 40 s. (A) minimal mPanx1 channel activities were 
recorded at -80 mV but substantial activities were detectable from Cx32-expressing 
cells. A conductance of Cx32 at ~185 pS (at -80 mV) was calculated based on the 
unitary amplitudes observed. (B) Single channel openings of mPanx1 when depolarised 
to 60 mV or 80 mV. These channel activities were abolished by 100 "M of NPPB. The 
unitary conductance of mPanx1 at 68 pS was estimated. 
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Discussion 
 
Panx1 assembles as a trimer at a plasma memebrane 
Early studies of Panx1 stoichiometry, based on cross-linking on solubilised 
protein, suggested that it is a hexamer [23]. In the present study, we investigated Panx1 
oligomerisation using different approaches. First, we found that the native Panx1 
quaternary structure using PFO-PAGE technique (a non-denaturing gel electrophoresis 
method) was trimeric. Cx32, known to form both hemichannels and gap junctions, was 
found to be a hexamer (as well as dodecamer) under the same experimental conditions. 
These findings were confirmed by analysis of Panx1 stoichiometry in living cells. Using 
homobifunctionnal (amine reactive) and non-membrane permeable cross-linkers, we 
found that a trimer represents the highest oligomeric state of Panx1 at the plasma 
membrane. Moreover, using membrane permeable cross-linker, we found a higher 
efficiency of cross-linking (in accordance with the poor membrane expression of Panx1) 
but no difference in the observed oligomeric state of Panx1. We observed Panx1 as a 
hexamer when cross-linking was performed after protein solubilisation (as described by 
Boassa et al. [23]), and we conclude that this reflects protein aggregation after 
solubilisation. Cross-linking by bifunctional amine reactive cross-linkers require specific 
lysine at the correct distance in both proteins, so we also used heterobifunctional amine- 
and photo-reactive diazirine cross-linkers which can covalently bind an amine group to 
several other functional group. We found no difference in Panx1 stoichiometry using 
these photoactivatable cross-linkers, supporting the interpretation that the trimer 
represents the oligomeric state of Panx1 in living cells.  
Based on immunocytochemistry and plasma membrane biotinylation, it has 
been proposed previously that rat Panx1 is highly expressed at the plasma membrane 
[23]. In our study, immunostaining of Panx1-transfected HEK cells confirmed that the 
protein is trafficked close to the plasma membrane; however, according to plasma 
membrane biotinylation, it is poorly expressed within the membrane. This might reflect a 
species difference – we have used mouse Panx1 whereas Boassa et al. used rat. A 
single amino acid difference might account for differences in membrane insertion, as we 
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observed in the case of K36E mutation (on mPanx1 plasmalemmal presence). 
Alternatively, the discrepancy may arise from the experimental procedure used for the 
plasma membrane biotinylation. In the previous work, after plasma membrane 
biotinylation, the authors purified plasma membrane proteins (using neutravidin agarose 
beads) and then detected Panx1 using a specific antibody. This procedure may reveal 
proteins that are not at the membrane but interact with plasma membrane proteins. 
These proteins together may be co-purified by the neutravidin beads. This explanation is 
supported by the presence of tubulin (known to be involved in the scaffolding of many 
membrane proteins) in the extracts [23]. Due to its nearby localisation to the plasma 
membrane (as confirmed by our immunostaining), such co-purification of Panx1 seems 
quite possible.  
After plasma membrane biotinylation, we immunoprecipitated Panx1 followed by 
Western blotting, and detected Panx1 using strepatvidin-HRP. This procedure directly 
reveals the biotinylation efficiency for Panx1, and thus gives a signal proportional to the 
quantity of Panx1 expressed at the plasma membrane. This experiment, together with 
the low efficiency of cross-linking using membrane impermeable cross-linker (see 
above), shows that Panx1 is poorly expressed at the plasma membrane. The single 
amino acid substitution (K36E) increased targeting to the membrane, as well as its 
function measured by membrane currents. This result suggests that this mutation may 
modify a motif involved in the interaction of Panx1 with others proteins, which regulate 
either its intracellular retention or plasma membrane stabilisation. Further work (such as 
a proteomic approach) will help to identify putative candidates for Panx1 interacting 
protein(s) and gain a better understanding of the plasma membrane trafficking of Panx1.  
 
Panx1 forms an anionic channel  
 Substitution of sodium ions in the extracellular solution with NMDG did not affect 
the Panx1 conductance. In contrast, changes in chloride concentration, either 
extracellular or intracellular, shifted the reversal potential of Panx1 currents as expected 
from changes in transmembrane chloride gradients (Fig. 3, 4). The slope of the 
relationship between reversal potential and the log10 of the chloride concentration 
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differed from the theoretical value predicted (58 mV fold per log unit) for a channel with 
exclusive chloride permeability. This difference arises from the fact that the channel is 
also significantly permeable to the “impermeable” ion used in these experiments 
(aspartate). The rank order of permeabilities (Table 1) determined using the Goldman-
Hodgkin-Katz equation was NO3 > I > Br > Cl > F >> aspartate ! glutamate ! gluconate. 
This order is the inverse of that of the size of the respective ions, and agrees with the 
sequence of halide mobility in free solution (the Eisenman selectivity sequence I, [26]). 
Furthermore this order of anion permeabilities is characteristic for many other anion 
channels including the newly identified TMEM16A channel [27]. Consistent with this 
demonstration of anion permeability was the observation that the Panx1-mediated 
currents were inhibited by known chloride channel blockers, with order of potency CBX > 
DIDS ! NPPB ! SITS > IAA-94 ! DCPIB > glibenclamide.  
 
Unitary Panx1 currents 
Unitary currents were readily activated following membrane depolarisation to 
levels more positive than + 10 mV, but these were never seen in non-transfected cells. 
These unitary Panx1 currents were inhibited by chloride channel blocker NPPB at the 
dame concentrations that blocked the whole cell currents. The single-channel 
conductance of about 68 pS was very different from the single-channel activity recorded 
for connexin 32, whose unitary currents were activated at negative potentials and had a 
conductance of ~190 pS.  
 
Panx1 signalling functions may not be associated with hemichannel  
From the very beginning of research on pannexins they were considered to act 
as gap junctional channels [2]; subsequently when the Panx-associated gap junctions 
were not identified in variety of tissues, pannexins were assigned the hemichannel role 
[28]. There is a considerable wealth of data demonstrating the involvement of Panx1 
proteins in diverse cellular functions and signalling cascades. Indeed, various 
manipulations with the levels of Panx1 expression or functional status, have identified 
their role in release of ATP and cytokines [4,7,10,15], stimulation of inflammatory 
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responses [29], shaping of synaptic responses in hippocampus [18], providing a 
hemichannel-related conductance in astrocytes [30] and mediating intercellular 
communication in taste buds [31]. Conceptually, the signalling role of connexon was, 
almost by default, associated with their hemichannel activity; it was generally considered 
(although never shown directly) that Panx1 effects are mediated primarily by the 
opening of large transmembrane pore.  
This interpretation, however, is not devoid of certain inconsistencies. First and 
foremost the Panx1-mediated currents were not recorded in native preparations. 
Second, the experiments on ectopic expression systems [3,10,11] consistently show 
activation of Panx1 channels only at positive membrane potentials (with a threshold of 
10 mV, and appreciable currents at > 40 mV). Most of the living cells are unable to 
generate such strong depolarisations; and even in excitable cells (e.g. neurones) these 
levels of membrane potential are attained for a very short periods during action potential 
overshoot. However, this apparent activation threshold is artificially determined by the 
(semi-equal) chloride gradient provided in the recording solutions. In real cells where 
such Cl equilibrium does not exist, a high [Cl]o/low [Cl]i gradient allows Panx1 currents to 
be activated at a much more negative potential (around -30 to -50 mV depending on the 
actual [Cl]i). Third, direct comparison of Panx1-mediated dye uptake and Panx1-
mediated currents showed clear dissociation between these two processes [10], thus 
questioning the pore-forming ability of pannexin proteins. Our results demonstrate that 
Panx1 forms an anion channel with relatively low conductance, which also argues 
against the alleged hemichannel role. We may suggest therefore that although Panx1 is 
involved in various signalling cascades, its action is not mediated through formation of 
hemichannels.  
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Materials and Methods 
 
Materials 
All the salts and drugs were purchased from Sigma-Aldrich (Poole, UK) unless 
otherwise stated. DCPIB was from Tocris (Bristol, UK). Cross-linkers, sulfo-NHS-LC-
biotin and streptavidin-HRP were purchased from Pierce (Cramlington, UK). PFO was 
from Fluorochem (Glossop, UK). The Flag and the HA antibodies were from Sigma-
Aldrich. The C-terminus Panx1 antibody was from Invitrogen (Paisley, UK). The Myc 
antibody was from Covance (Harrogate, UK). The EE antibody was from Bethyl 
laboratories (Montgomery, TX, USA). Streptavidin-Texas Red was from Vector 
laboratories (Peterborough, UK). Cell culture media (DMEM:F12 and Optimem) and 
lipofectamine were supplied by Invitrogen.  
 
Cell culture, transfection and peritoneal macrophage preparation 
HEK 293 cells were maintained in DMEM:F12 (1:1) medium supplemented with 
10% foetal calf serum (FCS) and 2 mM glutamine (Invitrogen). Lipofectamine 2000 
reagent (Invitrogen) was used for transfecting HEK cells under manufacturer’s 
instructions. Briefly, 1 "g (unless otherwise stated) of plasmid DNA and 0.1 "g of a 
plasmid encoding e-GFP (where necessary) were mixed with 3 "l of lipofectamine in 
Optimem. The mixture was transferred to a 35 mm petri dish of HEK cells. Cells were 
normally incubated in the DNA-lipofectamine medium for 4 to 24 hours before being 
plated on to coverslips. Biochemical/electrophysiological experiments were performed 
24 - 48 h after transfection. 
 
Electrophysiology 
Patch clamp recordings were performed using an EPC9 amplifier and the Pulse 
software (HEKA, Lambrect, Germany). Microelectrodes (resistance 5-9 M#) were 
prepared with a two-step electrode puller (Narishige, Tokyo, Japan). The standard 
extracellular/intracellular solution contained (in mM) 147 NaCl, 10 HEPES, 13 glucose, 2 
KCl, 2 CaCl2 and 1 MgCl2/147 NaCl, 10 HEPES and 10 EGTA, with pH adjusted to 7.3 
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with NaOH and the osmolarity around 300 mOsm. Other non-standard solutions are 
detailed when described. Cell membrane potential was held at -60 mV. For current-
voltage relationship experiments, voltage ramps (-120 to 70 mV) or voltage steps (-120 
to 80 mV with 20 mV increment) were applied in either whole-cell or cell-attached mode. 
For single channel recordings, 40 to 60 continuous recordings of 1 s were performed 
after outside-out configuration was obtained. Drugs were delivered via a rapid solution 
change system (RSC-200, Bio-logic Science Instruments, Grenoble, France). Acquired 
data were analysed using Axograph X software (AxoGraph Scientific, Sydney, Australia) 
and plotted by Kaleidagraph software (Synergy Software, Reading, PA, USA). Data are 
expressed as mean ± standard error and analysed via Student’s t test.  
 
Site-directed mutagenesis 
Point mutations of mouse Panx1 were introduced using the polymerase chain 
reaction (PCR) overlap extension method with Accuzyme proof-reading DNA 
polymerase (Bioline, London, UK). Mutagenised PCR fragments were digested with 
XbaI (New England Biolabs, Hitchin, UK) and cloned into an expression vector, pcDNA3 
(Invitrogen). The full coding sequence of all mutants was confirmed by DNA sequencing.  
 
Plasma membrane protein biotinylation, immunoprecipitation and Western 
blotting 
Transfected HEK cells (35mm dishes) were washed three times in ice-cold PBS 
containing 1 mM CaCl2 and 0.5 mM MgCl2 (PBS-CM). Cell surface expressed proteins 
were labelled using 1 mg/ml sulfo-NHS-LC-Biotin for 30 min at 4 °C in biotinylation 
buffer (10 mM H3BO3, 140 mM NaCl, pH 8.8). Cells were washed with PBS-CM and 
then incubated 5 min with PBS-CM containing 20 mM Tris pH 8.8. Lysis was performed 
by scraping cells in 500 µl of lysis buffer (20 mM Hepes, pH 7.4, 100 mM NaCl, 5 mM 
EDTA, 1% NP40, and the Complete set protease inhibitors cocktail (Roche, Welwyn 
Garden City, UK)). After 30 min of solubilisation at 4 °C under agitation, lysates were 
centrifuged (16,000 $ g, 10 min, 4 °C) and the supernatant was collected. 
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Equal amounts of protein (500–750 µg) were incubated with 20 µl of anti-flag-
conjugated agarose beads (Sigma) for 1 hour at 4 °C on a rotating wheel. Beads were 
washed three times (5 min at 4 °C) in lysis buffer. Proteins were eluted by two 
incubations with Flag peptide (200 "g/ml; 1 hour on a rotating wheel at 4°C). After 
adding of LDS sample buffer (invitrogen), proteins were heated at 80°C for 5 minutes, 
resolved on Bis-Tris gels (NuPage Novex, Invitrogen) or Tris-acetate gels (NuPage 
Novex, Invitrogen), transferred to PVDF membranes and blotted using either 
streptavidin–HRP, anti-flag-HRP, or Myc antibody. Signals were revealed using ECL 
Plus substrate (GE Healtcare, Chalfont St Giles, UK). Blots were analysed by 
densitometry measurements using the ImageJ software (National Institute of Health, 
Bethesda, MA, USA). 
 
Cross-linking of plasma membrane and intracellular proteins on living cells 
Cross-linking was performed as described above for plasma membrane protein 
biotinilation except that cross-linkers were used at a final concentration of 0.5 to 10 mM. 
For NHS-Diazirine (SDA) crosslinkers, after quenching with PBS-CM containing 20 mM 
Tris pH 8.8 and washes with PBS-CM, UV irradiation (using a 365 nm UV bulb) was 
performed for 10 min at 4°C before adding LDS sample buffer.  
 
PFO-PAGE 
Native gels were performed as previously described [19]. Briefly, nuclear 
fraction was removed by cells incubation in a hypotonic solution (20 mM Hepes pH 7.4, 
5 mM EDTA and the Complete set protease inhibitors cocktail) followed by syringing 10$ 
using a 1-ml syringe with a 25-G needle and centrifugation (10 min, 1,000 g at 4°C). 
Protein solubilisation was performed on supernatant by adding 2x loading buffer (100 
mM Tris base, 1% (w/v) NaPFO, 20% (v/v) glycerol, 0.005% Bromophenol Blue; pH 8.0 
with NaOH). After centrifugation (16,000 $ g, 10 min, 4 °C), electrophoresis was 
performed on an ice bath using 4-12% Tris-glycine gels (Invitrogen) and a running buffer 
containing 25 mM Tris, 192 mM glycine and 0.5% (w/v) PFO; pH 8.5 with NaOH. Prior to 
transfer on PVDF membrane, proteins were denaturated by incubation in a Tris-glycine 
 25 
buffer (25 mM Tris, 192 mM glycine) supplemented with SDS. Proteins detection was 
performed as described for Western blotting. 
 
Immunocytochemistry 
Transfected HEK cells were plated on polylysine-coated glass coverslips 24 
hours prior to immunostaining. After washes with PBS-CM, cells were fixed with 4% 
paraformaldehyde, 4% sucrose in PBS-CM for 5 min, washed in PBS-CM and then 
permeabilised by incubation for 5 min in PBS-CM supplemented with 0.1% Triton-X100 
and 0.5% BSA. Blocking of non-specific binding sites was performed by incubating cells 
with PBS-CM containing 0.5% BSA for 30 min. Cells were incubated with the primary 
antibody for 1 hour at 37°C. After PBS-CM / 0.5% BSA washes, fluorescent secondary 
antibodies were added for 1 hour at 37 °C. After extensive washing, coverslips were 
mounted. Images were acquired on a Delta Vision RT (Image Solutions, Preston, UK) 
restoration microscope. The images were collected using a Coolsnap HQ (Photometrics, 
Maidenhead, UK) camera with a Z optical spacing of 0.2 µm. Raw images were then 
deconvolved using the Softworx software and maximum intensity projections of these 
deconvolved images are shown in the results.  
For labelling of plasma membrane, living cells were incubated in PBS-CM + 
2mM NHS-LC-biotin (Pierce) for 30 min at 4°C before quenching (with PBS-CM, 20mM 
Tris pH8.8) and fixation. Strepatvidin-Texas Red was used to reveal plasma membrane 
proteins. 
Pictures were analysed by densitometry measurements using NIH ImageJ 
software. 
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Chapter 6 General Discussion
6.1 Controversies over the properties of Panx1
As the understanding of Panx1 grows, controversies over its properties continue 
to unfold. In contrast to the originally proposed role of a gap junction forming 
protein, the consensus has been reached that Panx1 is unable to provide the 
“docking” that is a prerequisite for the formation of a gap junction. The main 
evidence comes from a glycosylation site identified in the second extracellular 
loop that prevents two Panx1 units from docking together (Boassa et al, 2007). 
Although it is generally believed that Panx1 can operate as a hemichannel, the 
mechanism of Panx1 activation remains controversial. It is unclear, for example, 
how  Panx1 can be activated in vivo because the Panx1 currents can only be 
observed upon strong depolarisation in experimental systems (Bruzzone et al, 
2005; Ma et al, 2009). This thesis provides a plausible explanation for this 
apparent controversy by demonstrating chloride selectivity of  Panx1. In the 
majority of  experimental systems, the chloride gradient is minimal and therefore 
Panx1 currents reverse at around 0 mV; as a result the outward currents occur 
only at positive potentials. However, when a more physiological chloride gradient 
is provided (i.e. ~145 mM outside vs. 10-50 mM inside), the reversal potential of 
Panx1 currents shifts to the negative range (~ -30 mV). Therefore, a small 
depolarisation from the resting potential may be sufficient to induce the opening 
of the channel (Chapter 5 Paper III). 
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Intracellular calcium signals triggered via the purinergic P2Y receptor/PLC-
mediated pathway was proposed to trigger Panx1 activity (Locovei et al, 2006; 
Vanden Abeele et al, 2006). In these studies, the Panx1-attributed effects, such 
as dye transfer between cells or ATP release, rather than opening of the Panx1 
channel per se, were detected following manipulation of intracellular calcium 
concentrations. It should be emphasised that the direct recordings of Panx1 
channel openings in the in vivo systems have not been performed. Therefore, the 
very similar results can prompt completely opposite conclusions. Indeed, 
Leybaert and co-workers (2006) found that, unlike connexins, Panx1 cannot 
release ATP when [Ca2+]i is elevated (De Vuyst et al, 2006). Electrophysiological 
data presented in this thesis, however, do not support the role for intracellular 
calcium in regulation of Panx1 activity. Neither reduction of [Ca2+]i by BAPTA-AM, 
increases in [Ca2+]i by intracellular dialysis, nor modulation of the PLC pathway, 
affected Panx1 currents (Chapter 4 Paper II). 
Results presented in this thesis also challenge the generally accepted concept 
that Panx1 acts as a hemichannel. Arguments against a hemichannel role of 
Panx1 are as follows: firstly, Panx1 has strong preference to monovalent anions. 
This is supported by ion substitution and pharmacological studies. Secondly, both 
cell-attached and outside-out patch clamp recordings demonstrated a medium 
sized (~ 65 pS) unitary conductance of  Panx1, which is not consistent with typical 
hemichannels. Thirdly, stoichiometry studies performed in collaboration with 
Vincent Compan (Chapter 5 Paper III) revealed a trimeric oligomerisation state of 
Panx1, as contrast to hexamers for connexins. These observations justify the 
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main conclusion that Panx1 is a trimeric anion-selective ion channel rather than a 
hemichannel. 
6.2 Limitations to the study of Panx1
Several tools are available for studying the Panx1 but only a few  can be regarded 
as specific. 
Carbenoxolone (CBX) is a classical gap junction blocker and was the first 
pharmacological agent used to probe the functional expression of Panx1. CBX 
was found to be 10-fold more potent to Panx1 compared to connexins (Bruzzone 
et al, 2005). Indeed, CBX is the only gap junction blocker that can effectively 
inhibit Panx1, unlike heptanol or known gap junction mimetic peptides (Pelegrin 
and Surprenant, 2006). Because of the apparent selectivity shown by CBX to 
Panx1, many early studies relied on the action of CBX to define the functional 
role of Panx1. However, the specificity of  CBX remained unchallenged until CBX 
was reported to inhibit the swelling induced currents (Benfenati et al, 2009) and 
glutamate release in astrocytes upon hypotonic shock (Ye et al, 2009). 
Sequence mimetic peptides have proved to be useful in blocking connexin 
activation. Applying the same logic, Panx1 mimetic peptides were developed, of 
which 10Panx1 was found to be effective in inhibiting Panx1 function, namely the 
Panx1 currents, the alleged Panx1-mediated dye uptake, IL-1! release, ATP 
release and Panx1-induced NMDA currents (Pelegrin and Surprenant, 2006; 
Thompson et al, 2008). The mechanism of inhibition by this mimetic peptide 
remains to be established, however, two possibilities have been proposed: (i) the 
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inhibitory effect of the peptide was considered to be a steric block, which can be 
mimicked by polyethylene glycol (PEG) (Wang et al, 2007); and (ii) the 10Panx1 
peptide worked through a sequence-specific inhibition by targeting the first 
extracellular loop of  Panx1. However, the latter hypothesis assumed that the 
inhibition was caused by the peptide’s binding to the docking sites of  two 
neighbouring Panx1 units, which failed to explain the observation that 
neighbouring Panx1 units were unable to dock. In addition, a practical issue of 
using Panx1 mimetic peptide was the slow  onset of the effect. At least 10 minutes 
of incubation with 10Panx1 was required to inhibit Panx1 currents, compared to 
the inhibitory effect of CBX, which developed in only a few  seconds. Furthermore, 
the specificity of 10Panx1 might not be as high as expected (Wang et al, 2007). 
These authors showed that 10Panx1 inhibited not only the Panx1 but also Cx46 
currents in the oocyte expression system.
Transgenic Panx1 knock-out mice have been developed and these have been 
used to elucidate the functional role of Panx1. To date, however, there is no 
report of  studies in which these transgenic knock-out mice have been used. Our 
studies using these Panx1 knock-out mice (obtained from Hannah Monyer’s 
laboratory) do not provide compelling evidence to corroborate any Panx1 actions 
so far proposed. None of the events suggested to be associated with Panx1, 
including the ATP-triggered dye uptake, IL-1! release, cathepsin release, and the 
swelling-induced currents, were either abolished or reduced in these Panx1-
deficient mice. Notwithstanding, compensatory mechanisms may exist, although 
it could not be excluded that all the above-mentioned events are not mediated by 
Panx1 exclusively, if at all. 
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The siRNA in vitro knock-down strategy was probably the most convincing 
approach in providing direct evidence for Panx1’s actions. The Panx1 gene has 
been successfully knocked down in different preparations, including cell lines 
(e.g., LNCaP cells (Vanden Abeele et al, 2006) and HEK cells (Pelegrin and 
Surprenant, 2006)), and cultured primary cells (astrocytes (Locovei et al, 2007; 
Iglesias et al, 2009) and hippocampal neurones (Thompson et al, 2008)). In 
these studies, the proposed Panx1’s functions were significantly reduced when 
cells were transfected with the Panx1-siRNA, compared to those transfected with 
scramble control siRNA. However, the siRNA knock-down method does have 
some drawback. Firstly, a high level of efficiency of  siRNA transfection was not 
easily achievable, especially in native tissues. Secondly, long incubation with 
Panx1-siRNA was required before the activities of  cells can be assessed. No 
acute inhibition of the channel activity was therefore possible using this 
approach.
To conclude, effective and specific tools to probe the role of  Panx1 have yet to be 
identified. A wide range of  pharmacological agents and mimetic peptides can only 
be selected by high-throughout screening but the hindrance of this approach is 
that it lacks a specific action to identify Panx1. Although many downstream 
activities have been suggested to be Panx1-related, none of them is 
unequivocally attributed to Panx1. 
6.3 Actions of Panx1 
Panx1 displays outwardly rectifying currents. However, similar current-voltage 
profile have also been described for BK channels (Petroff et al, 2008), some 
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TrpM channels (Runnels et al, 2002) and the volume-regulated anion channel 
(VRAC) currents (Jackson and Strange, 1995). Furthermore, Panx1 currents 
displayed similar ionic preference and unitary conductance to the VRAC currents. 
Therefore, electrophysiological properties alone are not sufficient to differentiate 
Panx1 from other channels. As discussed previously, specific pharmacological 
tools are needed but they are yet to be identified. 
The P2X7-induced dye uptake was considered to be mediated by Panx1 
(Pelegrin and Surprenant, 2006). However, this thesis provides direct 
experimental data that question the role of  Panx1 in the P2X7 “pore” formation. 
Evidence is presented to show  that Panx1 is an ion channel with strong 
preference to anions, having a medium unitary conductance and a non-
hemichannel like oligomeric state. It is prudent to state that more evidence is 
required to conclude whether Panx1 is indeed associated with the “pore” for the 
P2X7 receptor, or behaves as a regulatory protein of  the dye uptake event. It is 
also not conclusive to attribute dye uptake, at least as yet, to Panx1 and or to use 
this parameter to probe the existence of Panx1.
None of  the other proposed Panx1-associated activities have so far been found 
to be restricted to Panx1. For instance, ATP release can be mediated by 
exocytosis, via the ABC tansporters, connexins, volume-regulated anion 
channels as well as Panx1. Furthermore, studies on the Panx1-deficient mice 
showed that IL-1! release, ATP release and cathepsin release remained 
unaltered (unpublished data from our laboratory), although all these actions had 
been proposed to be Panx1-related. This strongly suggests that roles attributed 
to Panx1 are by no means unique, but shared with other proteins 
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To summarise, most of the Panx1-associated functions are not exclusively linked 
with Panx1. Therefore, it is prudent not to rely on just one of such functions to 
identify Panx1’s existence. Care must be taken to employ a selection of  Panx1-
related actions to ensure that Panx1 is indeed being studied. 
6.4 Panx1 as a novel Cl- channel
Until the recent discoveries of  new  members, the Cl- channels remained mostly 
under-explored. In 2008, three independent groups identified TMEM16A as a 
novel calcium-activated Cl- channel (CaCC) (Caputo et al, 2008; Schroeder et al, 
2008; Yang et al, 2008). However, our understanding of Cl- channels is still 
incomplete. 
This thesis presents compelling evidence demonstrating that Panx1 is a new  Cl- 
channel. Panx1 has a strong preference to anions over cations but has a low 
selectivity among monovalent anions. The rank order of its anion preference is I- 
> Br- > Cl- > F- > aspartate " glutamate " gluconate, which is known as the 
Eisenman’s Sequence I. This feature is shared by many Cl- channels (e.g. Yang 
et al, 2008). The present pharmacology data showed that the Panx1 currents can 
be inhibited by a spectrum of non-specific Cl- channel blockers. The unitary 
conductance of  Panx1 was calculated to be 65 pS, a value which is lower than 
that predicted for a hemichannel. Moreover, analysis of stoichiometry 
demonstrated that Panx1 oligomerises as dimers or trimers, but not as hexamers 
as hemichannel proteins do. Furthermore, the activation of Panx1 is not 
99
dependent on either extracellular or intracellular calcium, unlike connexin 
hemichannels.
Panx1 share some similarities with the volume-regulated anion channels (VRAC), 
whose molecular identity is still unknown. The ionic preference for both channels 
follows the Einsenman’s Sequence I; both Panx1-mediated and the swelling-
induced currents mediated by VRAC (known as “ICl, swell”) can be blocked by CBX 
(Figure 6.4) and both currents can be inhibited by extracellular ATP at millimolar 
concentrations (Ma et al, 2009; Jackson and Strange, 1995). The only difference 
observed is that Panx1 currents display a stronger outward rectification than ICl, 
swell, although it could be due to the difference between over-expressed and 
endogenously expressed channels. However, when the swelling-induced currents 
were studied on peritoneal macrophages from Panx1-knock-out mice, it was 
found that they displayed normal ICl, swell with identical kinetics as that from the 
wild type animals (Figure 6.4C). Indeed, 10Panx1, a mimetic peptide designed to 
inhibit Panx1 currents, failed to block ICl, swell recorded from wild type peritoneal 
macrophages. From our data, it can be concluded that Panx1 functions as a Cl- 
channel , but is distinct from the swelling-induced currents.
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Figure 6.4 Panx1 is not directly responsible for the swelling-induced currents
Mouse peritoneal macrophages, which endogenously express Panx1, were 
challenged with a hypotonic solution (50% of the standard extracellular solution). 
The evoked currents were recorded by voltage steps (-120 to +120 mV) (A) or 
ramps (-100 to +100 mV) (B). The current-voltage profile showed an outward 
rectification, which was similar to Panx1’s. The swelling-induced currents were 
blocked by 100 µM CBX (A, B and C) and 100 µM tamoxifen (C). Cells from the 
Panx1-deficient mice also displayed swelling-induced currents with a similar 
kinetics to the wild type(C). 
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6.5 Structure-function studies of Panx1
To further understand the Panx1 channel, the molecular basis for its Cl- selectivity 
was investigated. Positively-charged residues in the putative extracellular and 
transmembrane domains of Panx1 were mutated to a negatively charged 
residue, glutamic acid (E). Out of all the mutations made, two mutants, K36E and 
R299E, displayed at least 5-fold increase in the whole-cell current amplitude. The 
large current amplitude was unlikely to be explained by an increase in 
permeation to Cl-, because the mutagenesis strategy was to disrupt the electrical 
attraction by replacing the positively charged residues to one with the opposite 
charge. In addition, these two residues are located at the bottom of the putative 
transmembrane domains 1 and 4, making them unlikely to be the lining of  the 
permeation pathway. It was hypothesised that these mutations may enhance the 
membrane expression of Panx1. This was proved by membrane biotinylation 
studies performed by a colleague, Vincent Compan. However, these mutants do 
not match with any known motif involved in the trafficking process to direct 
proteins from endoplasmic reticulum to plasma membrane. Whether these 
mutations provide the basis for an interaction between Panx1 and some 
trafficking regulatory proteins remains to be explored.
All the mutations of the positively-charged residues in the putative second 
transmembrane region (TM2) caused a loss-of-function of the channel. This 
suggests that the TM2 may be critical in ion permeation and/or gating of the 
channel. A cysteine scanning was, therefore, necessary to further elucidate the 
selectivity pore of  Panx1. However, application of  methanethiosulfonate-
ethyltrimethlammonium (MTSET), a compound modifies cysteine residues 
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(Rassendren et al, 1997), induced leaking currents from the wild type Panx1, 
making cysteine scanning impossible to be carried out. The most probable cause 
for this leaking current is the four cysteine residues in the extracellular domains 
of the channel. These four cysteines are highly conservative among the 
pannexin, connexin and innexin families. Replacement of  these cysteines by 
alanine rendered the Panx1 channel non-functional. 
A significant difference in the functional expression of  Panx1 exists between the 
human and mouse variants. The human Panx1 currents seemed considerably 
more difficult to record (Ma et al, 2009), although their average or maximal 
amplitudes were similar to the mouse counterpart. The difference could not be 
explained in terms of  differential level of membrane expression of  these proteins, 
as similar levels were found in membrane staining experiments. The human and 
mouse Panx1 share > 85% homology in their overall amino acid sequences but 
the similarity falls to ~ 50% in the putative C-terminus. This suggests that a motif 
may exist in this region to control functional expression of  the channel. Future 
studies of  chimeras containing the C-terminus of  a different species may be 
required to further explore the impact of the C-terminus on functional expression 
of Panx1.
6.6 Back to the original question: what is responsible for the P2X7 dye 
uptake?
The scope of this thesis was to study Panx1 in the absence of  the P2X7R. With 
the original finding (Pelegrin and Surprenant, 2006) that the functional role Panx1 
was tightly associated with the P2X7R, and with the view  that the properties of 
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Panx1 have been challenged by this thesis, it is essential to re-examine the 
involvement of Panx1 in the large molecule permeation pathway for the P2X7R. 
Although there is an abundant amount of data suggesting the involvement of a 
separate protein (for example, Panx1) in the P2X7 permeability dynamics (Petrou 
et al, 1997; Jiang et al, 2005), some studies showed that the increase of 
permeability may be a dilatation process of the P2X7 channel itself (Khakh et al, 
1999; Yan et al, 2008). In favour of a separate protein serving as the “large pore”, 
one can argue that the dye uptake phenomenon is not only observed in P2X7 but 
also in TRPA1 (Karashima et al, 2010) and TRPV1 (Chung et al, 2008) 
expressing cells, hence the existence of  a common “pore”. To investigate that 
pore formation did not require Panx1, conformational changes of other P2X 
receptors were compared. Direct microscopic observations of  P2X4 or P2X2 dye 
uptake revealed that their pore dilatation did not require Panx1 (Chaumont and 
Khakh, 2008; Shinozaki et al, 2009). Indeed, findings from this thesis that 
Panx1’s function is a Cl- channel rather than a hemichannel disputes the 
argument that large molecules actually go through Panx1.  
Further to the question of whether the P2X7 “pore” is an intrinsic property of the 
channel itself or provided by another protein has resulted in the proposal of the 
existence of  regulatory proteins for P2X7 pore formation. For example, Gu et al 
(2009) demonstrated that the non muscle myosin heavy chain IIA (NMMHC-IIA), 
a part of the cytoskeleton protein myosin, was a limiting factor of the P2X7 pore 
dilatation (Gu et al, 2009). Although these regulatory proteins provide new  insight 
into the large conductance of the P2X7 permeation pathway, the same question 
remains: what do these regulatory proteins regulate? Is it the P2X7R itself or 
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other proteins that provide conduit for large molecules? A universal model that 
covers all types of tissues seems hard to propose. The P2X7 dye uptake 
phenomenon will perhaps remain unresolved until detailed structure of the P2X7R 
and live monitoring of its conformational change become available. 
6.7 Future work
The main aim of this project was to investigate the biophysical and 
electrophysiological nature of Panx1. It has been shown that Panx1 is an anion-
selective channel. However, the molecular foundation of such selectivity has yet 
not been established. Therefore, further experiments employing mutagenesis are 
required to identify the critical regions responsible for Panx1’s permeation to 
anions. Particular areas to explore include the C-terminus of the protein, which 
displays the most significant divergence between the human and mouse 
homologues, and the putative second transmembrane domain due to its high 
content of positively-charged residues. 
 
In addition, the role of Panx1 in P2X7 dye uptake needs to be re-examined. This 
thesis has provided clear evidence against Panx1 as a hemichannel, thereby 
challenging its role as the direct large molecular permeation pathway for the 
P2X7 receptor. Because Panx1 has been shown to be highly selective to Cl-, real-
time changes of  intracellular [Cl-] can be monitored using fluorescent indicators to 
detect the involvement of Panx1 in the P2X7-associated events, such as dye 
uptake. A combination of imaging and electrophysiology methods can also be 
employed to record Panx1 channel openings (i.e. the Panx1 currents) 
simultaneously with dye uptake.
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Finally, the interacting proteins of Panx1 remain an uncharted area in the Panx1 
study. A proteomics approach may be considered to screen potential interacting 
proteins with Panx1. Progress in this area will help to better understand how 
Panx1 is regulated, how  it works as a Cl- channel, its contribution to the P2X7-
associated events, and may provide insights into new  functions of Panx1 that 
have not yet been proposed. 
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